00000000|MMI|204.99|Portugal|C0032729|[geoa]|["PO"-tx-10-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|2415/2;2068/2;1836/2;[1668/2],[1733/2];[879/2],[1100/2],[1193/2],[1428/2],[1542/2];[568/2],[654/2],[714/2],[776/2]|Z01.542.727
00000000|MMI|135.97|Override|C1547671|[acty]|["Override"-tx-11-"override"-verb-0,"Override"-tx-10-"Override"-verb-0,"Override"-tx-10-"overridden"-noun-0,"Override"-tx-10-"override"-verb-0,"Override"-tx-8-"Override"-verb-0,"Override"-tx-8-"override"-verb-0,"Override"-tx-6-"Override"-verb-0,"Override"-tx-6-"override"-verb-0,"Override"-tx-4-"Override"-verb-0,"Override"-tx-3-"override"-verb-0,"Override"-tx-2-"Override"-verb-0]|TX|2648/8;2442/8;2430/10;2368/8;2225/8;[2171/8],[2203/8];1996/8;[1949/8],[1974/8];[1742/8],[1759/8];999/8;[785/8],[802/8]|
00000000|MMI|126.75|Lovenox|C0728963|[orch,phsu]|["Lovenox"-tx-56-"lovenox"-noun-0,"Lovenox"-tx-51-"lovenox"-noun-0,"Lovenox"-tx-43-"lovenox"-noun-0,"Lovenox"-tx-34-"lovenox"-noun-0,"Lovenox"-tx-19-"lovenox"-noun-0,"Lovenox"-tx-2-"LOVENOX"-noun-0]|TX|7218/7;6874/7;6624/7;6064/7;[4357/7],[4565/7];721/7|D09.698.373.400.300.200
00000000|MMI|114.06|Oral|C0442027|[spco]|["Oral"-tx-19-"oral"-adj-0,"PO"-tx-10-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|4221/4;2415/2;2068/2;1836/2;[1668/2],[1733/2];[879/2],[1100/2],[1193/2],[1428/2],[1542/2];[568/2],[654/2],[714/2],[776/2]|
00000000|MMI|106.31|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-59-"DISCHARGE"-noun-0,"Discharge"-tx-56-"DISCHARGE"-noun-0,"Discharge"-tx-12-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|7336/9;7152/9;3022/9;512/9;204/9;299/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|102.51|Fenofibrate|C0033228|[orch,phsu]|["Phenofibrate"-tx-19-"fenofibrate"-noun-0,"Phenofibrate"-tx-10-"FENOFIBRATE"-noun-0,"Phenofibrate"-tx-3-"FENOFIBRATE"-noun-0,"Phenofibrate"-tx-2-"FENOFIBRATE"-noun-0]|TX|4582/11;2507/11;945/11;757/11|D02.241.081.114.968.500.625;D02.355.726.305.625;D02.455.426.559.389.115.124.750;D02.455.426.559.389.657.654.305.625;D02.522.223.750
00000000|MMI|99.37|Mongolia|C0026410|[geoa]|["MG"-tx-10-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0,"MG"-tx-3-"MG"-noun-0,"MG"-tx-2-"MG"-noun-0]|TX|2412/2;1665/2;[1097/2],[1190/2],[1385/2],[1539/2];[651/2],[711/2]|Z01.252.474.651
00000000|MMI|75.88|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-33-"ASA"-noun-0,"ASA"-tx-19-"ASA"-noun-0,"Acetylsalicylic Acid"-tx-2-"ACETYLSALICYLIC ACID"-noun-0]|TX|6008/3;4526/3;588/20|D02.455.426.559.389.657.410.595.176
00000000|MMI|72.55|Cerebrovascular accident|C0038454|[dsyn]|["CVA, NOS"-tx-43-"CVAs"-noun-0,"CVA, NOS"-tx-34-"CVA"-noun-0,"CVA, NOS"-tx-19-"CVA's"-noun-0,"CVA, NOS"-tx-12-"CVA"-noun-0,"CVA, NOS"-tx-12-"CVA's"-noun-0]|TX|6606/4;6076/3;4338/5;3224/3;3608/5|C10.228.140.300.775;C14.907.253.855
00000000|MMI|67.13|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-8-"SIMVASTATIN"-noun-0,"SIMVASTATIN"-tx-6-"SIMVASTATIN"-noun-0,"SIMVASTATIN"-tx-3-"SIMVASTATIN"-noun-0]|TX|2148/11;1926/11;976/11|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|67.08|Zocor|C0678181|[orch,phsu]|["Zocor"-tx-7-"ZOCOR"-noun-0,"Zocor"-tx-5-"ZOCOR"-noun-0,"Zocor"-tx-3-"ZOCOR"-noun-0]|TX|2062/5;1830/5;873/5|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|63.07|Niacin|C0027996|[phsu,vita]|["NIACIN"-tx-10-"NIACIN"-noun-0,"NIACIN"-tx-9-"NIACIN"-noun-0,"NIACIN"-tx-7-"NIACIN"-noun-0,"NIACIN"-tx-5-"NIACIN"-noun-0]|TX|2592/6;2339/6;2124/6;1902/6|D03.066.515.475;D03.383.725.547.475
00000000|MMI|59.79|Daily|C0332173|[tmco]|["Daily"-tx-55-"daily"-adj-0,"Daily"-tx-36-"daily"-adv-0,"QD"-tx-20-"QD"-adv-0,"QD"-tx-19-"QD"-noun-0,"Daily"-tx-10-"DAILY"-adv-0,"Daily"-tx-4-"DAILY"-adj-0,"Daily"-tx-3-"DAILY"-adj-0,"Daily"-tx-3-"DAILY"-adv-0,"Daily"-tx-2-"DAILY"-adj-0]|TX|6983/5;6295/5;5459/2;4695/2;2418/5;1736/5;[1103/5],[1196/5],[1455/5],[1545/5];[1103/5],[1196/5],[1455/5],[1545/5];[619/5],[657/5],[779/5]|
00000000|MMI|59.50|Lantus|C0876064|[aapp,phsu]|["Lantus"-tx-49-"Lantus"-noun-0,"Lantus"-tx-48-"lantus"-noun-0,"Lantus"-tx-3-"LANTUS"-noun-0]|TX|6826/6;6726/6;1268/6|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|58.93|Coding|C0009219|[ocac]|["code"-tx-53-"Code"-noun-0,"code"-tx-2-"CODE"-noun-0,"code"-tx-2-"code"-noun-0]|TX|6895/4;459/4;477/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|45.85|Awareness|C0004448|[menp]|["Aware"-tx-11-"aware"-adj-0,"Aware"-tx-10-"aware"-adj-0,"Aware"-tx-6-"aware"-adj-0,"Aware"-tx-3-"aware"-adj-0]|TX|2661/5;2378/5;1959/5;1009/5|F02.463.188.150
00000000|MMI|42.77|Troponin|C0041199|[aapp,bacs]|["Troponin"-tx-31-"troponin"-noun-0,"Troponin"-tx-29-"troponin"-noun-0,"troponins"-tx-20-"troponins"-noun-0]|TX|5868/8;5761/8;5377/9|D05.750.078.730.825;D12.776.210.500.910;D12.776.220.525.825
00000000|MMI|42.58|Glipizide|C0017642|[orch,phsu]|["GLIPIZIDE"-tx-49-"glipizide"-noun-0,"GLIPIZIDE"-tx-47-"glipizide"-noun-0,"GLIPIZIDE"-tx-19-"glipizide"-noun-0]|TX|6801/9;6707/9;4613/9|D02.886.590.795.500
00000000|MMI|42.46|Peptide Nucleic Acids|C0600500|[nnon]|["PNA"-tx-20-"pna"-noun-0,"PNA"-tx-13-"pna"-noun-0,"PNA"-tx-12-"pna"-noun-0]|TX|5179/3;3641/3;3487/3|D13.695.578.424.550
00000000|MMI|42.38|Atorvastatin calcium|C0286650|[orch,phsu]|["ATORVASTATIN CALCIUM"-tx-11-"ATORVASTATIN CALCIUM"-noun-0,"ATORVASTATIN CALCIUM"-tx-10-"ATORVASTATIN CALCIUM"-noun-0,"ATORVASTATIN CALCIUM"-tx-9-"ATORVASTATIN CALCIUM"-noun-0]|TX|2616/20;2538/20;2312/20|D03.383.129.578.075;D10.251.450.200
00000000|MMI|42.26|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-3-"SC"-noun-0,"SC"-tx-2-"SC"-noun-0]|TX|[1238/2],[1305/2];750/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|41.95|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-12-"DIAGNOSIS"-noun-0]|TX|[2979/9],[3147/9]|x.x.x.x.x.x.x
00000000|MMI|39.51|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-33-"ASA"-noun-0,"ASA"-tx-19-"ASA"-noun-0]|TX|6008/3;4526/3|D08.811.277.352.827.070.250
00000000|MMI|39.26|NovoLog|C0939412|[aapp,phsu]|["NovoLog"-tx-49-"novolog"-noun-0,"NovoLog"-tx-3-"NOVOLOG"-noun-0]|TX|6841/7;1202/7|D06.472.699.587.200.400.100;D12.644.548.586.200.400.100
00000000|MMI|39.26|Walking (activity)|C0080331|[dora]|["Walking"-tx-15-"walking"-noun-0,"Walking"-tx-11-"Walking"-noun-0]|TX|3741/7;2764/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|38.96|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-56-"treatment"-noun-0,"treatment"-tx-12-"Treatment"-noun-0]|TX|7203/9;3209/9|x.x.x.x.x.x.x
00000000|MMI|35.50|Disease|C0012634|[dsyn]|["condition"-tx-56-"CONDITION"-noun-0,"Disorder"-tx-43-"disorder"-noun-0,"Disease"-tx-19-"disease"-noun-0,"condition"-tx-12-"Conditions"-noun-0]|TX|7162/9;6637/8;4196/7;3157/10|C23.550.288
00000000|MMI|34.07|Rabbi|C0684010|[prog]|["R."-tx-37-"R"-noun-0,"R."-tx-20-"R"-adj-0,"R."-tx-12-"R"-noun-0]|TX|6340/1;5132/1;3411/1|M01.526.799.500
00000000|MMI|33.73|Gastroesophageal reflux disease|C0017168|[dsyn]|["GERD"-tx-19-"GERD"-noun-0,"GERD"-tx-12-"GERD"-noun-0]|TX|4483/4;3235/4|C06.405.117.119.500.484
00000000|MMI|33.56|District of Columbia|C0012764|[geoa]|["D.C."-tx-49-"d/c"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|6794/3;375/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|33.49|Acid Ceramidase|C2350443|[aapp,enzy]|["AC"-tx-49-"AC"-noun-0,"AC"-tx-3-"AC"-noun-0]|TX|6838/2;1241/2|D08.811.277.087.250.100
00000000|MMI|30.97|Togo|C0040363|[geoa]|["TO"-tx-55-"to"-adv-0,"TO"-tx-30-"to"-adv-0]|TX|7112/2;5822/2|Z01.058.290.190.800
00000000|MMI|30.97|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-55-"to"-adv-0,"TO"-tx-30-"to"-adv-0]|TX|7112/2;5822/2|D08.811.520.224.800
00000000|MMI|28.44|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-57-"M.D"-noun-0,"M.D."-tx-8-"M.D"-noun-0,"M.D."-tx-7-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-3-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|7286/3;2274/3;2044/3;1812/3;855/3;454/3|
00000000|MMI|28.36|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-19-"lipitor"-noun-0,"Lipitor"-tx-10-"LIPITOR"-noun-0]|TX|4600/7;2384/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|28.21|Seizures|C0036572|[sosy]|["sz"-tx-43-"sz"-noun-0,"seizure d"-tx-19-"seizure d"-noun-0]|TX|6634/2;4432/9|C10.228.140.490.631;C10.597.742;C23.888.592.742
00000000|MMI|28.20|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-20-"EKG"-noun-0,"EKG"-tx-17-"EKG"-noun-0]|TX|5271/3;3858/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|28.20|Electrocardiography|C1623258|[diap]|["EKG"-tx-20-"EKG"-noun-0,"EKG"-tx-17-"EKG"-noun-0]|TX|5271/3;3858/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|28.16|Coronary Artery Bypass Surgery|C0010055|[topp]|["CABG"-tx-19-"CABG"-noun-0,"CABG"-tx-12-"CABG"-noun-0]|TX|4028/4;3248/4|E04.100.376.719.332;E04.100.814.868.750;E04.928.220.520.220
00000000|MMI|28.12|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-19-"lisinopril"-noun-0,"Lysinopril"-tx-3-"LISINOPRIL"-noun-0]|TX|4549/10;1435/10|D12.644.456.345.600
00000000|MMI|28.01|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-3-"Food/Drug Interaction"-noun-0]|TX|[1109/21],[1551/21]|G07.690.773.968.511
00000000|MMI|28.01|Antigua and Barbuda|C0003354|[geoa]|["AC"-tx-49-"AC"-noun-0,"AC"-tx-3-"AC"-noun-0]|TX|6838/2;1241/2|Z01.107.084.900.050;Z01.639.880.050
00000000|MMI|26.58|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-10-"MG"-noun-0,"Mg++"-tx-4-"MG"-noun-0,"Mg++"-tx-3-"MG"-noun-0,"Mg++"-tx-2-"MG"-noun-0]|TX|2412/2;1665/2;[1097/2],[1190/2],[1385/2],[1539/2];[651/2],[711/2]|
00000000|MMI|26.58|Milligram percent|C1960952|[qnco]|["mg %"-tx-10-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0,"mg %"-tx-3-"MG"-noun-0,"mg %"-tx-2-"MG"-noun-0]|TX|2412/2;1665/2;[1097/2],[1190/2],[1385/2],[1539/2];[651/2],[711/2]|
00000000|MMI|26.58|mg/dL|C0439269|[qnco]|["mg%"-tx-10-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0,"mg%"-tx-3-"MG"-noun-0,"mg%"-tx-2-"MG"-noun-0]|TX|2412/2;1665/2;[1097/2],[1190/2],[1385/2],[1539/2];[651/2],[711/2]|
00000000|MMI|26.35|Obesity|C0028754|[dsyn]|["OBESE"-tx-20-"obese"-adj-0]|TX|4959/5|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|26.32|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-19-"HTN"-noun-0,"HTN"-tx-12-"HTN"-adj-0,"HTN"-tx-12-"HTN"-noun-0]|TX|4205/3;[3240/3],[3552/3];[3240/3],[3552/3]|C14.907.489
00000000|MMI|26.27|Pneumonia|C0032285|[dsyn]|["PNEUMONIA"-tx-22-"pneumonia"-noun-0,"PNEUMONIA"-tx-12-"pneumonia"-noun-0,"PNEUMONIA"-tx-1-"pneumonia"-noun-0]|TX|5487/9;3102/9;75/9|C08.381.677;C08.730.610
00000000|MMI|25.52|Hospital admission|C0184666|[hlca]|["Admission"-tx-49-"admission"-noun-0,"Admit"-tx-20-"Admit"-verb-0,"Admit"-tx-19-"Admit"-verb-0,"Admit"-tx-17-"admit"-verb-0,"Admit"-tx-13-"admit"-verb-0,"Admission"-tx-12-"Admission"-noun-0,"Admit"-tx-12-"ADMIT"-verb-0]|TX|6779/9;5096/5;4515/5;3865/5;3622/5;3079/9;2973/5|
00000000|MMI|25.48|Consultation|C0009818|[hlca]|["consulted"-tx-32-"Consulted"-verb-0,"Consults"-tx-20-"Consults"-verb-0]|TX|5937/9;5298/8|N04.452.758.849
00000000|MMI|25.05|Ceftriaxone|C0007561|[antb,orch]|["Ceftriaxon"-tx-23-"ceftriaxone"-noun-0]|TX|5509/11|D02.065.589.099.249.190.190.155;D02.886.665.074.190.190.155;D04.075.080.875.099.221.249.190.190.155
00000000|MMI|23.62|Bisacodyl|C0005632|[orch,phsu]|["BISACODYL"-tx-2-"BISACODYL"-noun-0]|TX|636/9|D02.455.426.559.389.657.239.132
00000000|MMI|23.62|Heme|C0018966|[bacs,orch]|["Haem"-tx-38-"Heme"-noun-0]|TX|6418/4|D03.383.129.578.840.500.640.587;D03.549.909.500.640.587;D04.345.783.500.640.587;D23.767.727.640.587
00000000|MMI|23.25|ferrous sulfate|C0060282|[inch,phsu]|["Ferrous sulphate"-tx-3-"FERROUS SULFATE"-noun-0,"Iron sulphate"-tx-3-"IRON SULFATE"-noun-0]|TX|1075/15;1060/12|x.x.x.x
00000000|MMI|23.10|10%|C3842590|[fndg]|["10%"-tx-59-"10"-fraction-0,"10%"-tx-19-"10"-integer-0,"10%"-tx-10-"10"-fraction-0,"10%"-tx-8-"10"-fraction-0,"10%"-tx-2-"10"-integer-0,"10%"-tx-1-"10"-fraction-0]|TX|7308/2;4623/2;2460/2;2245/2;648/2;[142/2],[183/2]|
00000000|MMI|23.05|Physicians|C0031831|[prog]|["PHYSICIAN"-tx-55-"physician"-noun-0,"DR"-tx-11-"Dr"-noun-0]|TX|7102/9;2895/2|M01.526.485.810;N02.360.810
00000000|MMI|22.77|Christmas Island|C0006888|[geoa]|["CXR"-tx-27-"CXR"-noun-0,"CXR"-tx-20-"CXR"-noun-0]|TX|5618/3;5102/3|Z01.639.100;Z01.678.100.373
00000000|MMI|22.76|Diet|C0012155|[food]|["Diet"-tx-11-"DIET"-noun-0]|TX|[2667/4],[2734/4]|G07.203.650.240
00000000|MMI|22.72|Vancomycin|C0042313|[aapp,antb]|["VANCO"-tx-24-"vanco"-noun-0,"VANCO"-tx-23-"vanco"-noun-0]|TX|5552/5;5533/5|D09.400.420.925;D12.644.233.925;x.x.x.x
00000000|MMI|22.71|Fever|C0015967|[fndg]|["Febrile"-tx-35-"febrile"-adj-1,"FEVER"-tx-15-"fever"-noun-0]|TX|6118/7;3760/5|C23.888.119.344
00000000|MMI|22.67|Home visit (procedure)|C0020043|[hlca]|["home services"-tx-2-"Home services"-noun-0,"home services"-tx-1-"Home services"-noun-0]|TX|495/4,503/8;356/13|N04.452.758.307
00000000|MMI|22.59|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-49-"d/c"-noun-0,"D & C"-tx-1-"D/C"-noun-0]|TX|6794/3;375/3|E04.157.310;E04.950.300.299
00000000|MMI|22.42|ECHO protocol|C0058928|[topp]|["ECHO"-tx-37-"echo"-noun-0,"ECHO"-tx-20-"Echo"-noun-0]|TX|6335/4;5183/4|x.x.x.x
00000000|MMI|22.23|Dulcolax|C0591416|[orch,phsu]|["Dulcolax"-tx-2-"DULCOLAX"-noun-0]|TX|625/8|D02.455.426.559.389.657.239.132
00000000|MMI|22.23|Weight Gain|C0043094|[fndg]|["increase weight"-tx-55-"weight increases"-noun-0]|TX|7025/16|C23.888.144.243.926;G07.700.320.249.314.120.200.926
00000000|MMI|22.16|Atrovent|C0591130|[orch,phsu]|["Atrovent"-tx-3-"ATROVENT"-noun-0]|TX|1336/8|D02.145.074.722.229.400;D03.132.760.180.572.400;D03.132.889.180.648.400;D03.605.869.229.400;D04.075.080.875.099.722.229.400
00000000|MMI|22.16|Ipratropium|C0027235|[orch,phsu]|["IPRATROPIUM"-tx-3-"IPRATROPIUM"-noun-0]|TX|1357/11|D02.145.074.722.229.400;D03.132.760.180.572.400;D03.132.889.180.648.400;D03.605.869.229.400;D04.075.080.875.099.722.229.400
00000000|MMI|20.88|Antibiotics, Antitubercular|C0003237|[antb]|["Antibiotics"-tx-12-"antibiotics"-noun-0]|TX|3416/11|D27.505.954.122.085.255.135
00000000|MMI|20.88|Creatine Kinase MB Isoenzyme|C0010290|[aapp,enzy]|["CK-MB"-tx-31-"CK mb"-noun-0]|TX|5907/5|D08.811.913.696.640.150.625
00000000|MMI|20.88|Hydroxymethylglutaryl-CoA Reductase Inhibitors|C0360714|[orch,phsu]|["Statin"-tx-33-"statin"-noun-0]|TX|6031/6|D27.505.519.186.071.202.370;D27.505.519.389.370;D27.505.954.557.500.202.370
00000000|MMI|20.88|Insulin Aspart|C1708521|[aapp,horm,phsu]|["Insulin Aspart"-tx-3-"INSULIN ASPART"-noun-0]|TX|1212/14|D06.472.699.587.200.400.100;D12.644.548.586.200.400.100
00000000|MMI|20.88|Insulin Glargine|C0907402|[aapp,horm,phsu]|["INSULIN GLARGINE"-tx-3-"INSULIN GLARGINE"-noun-0]|TX|1277/16|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|20.88|Phenytoin|C0031507|[orch,phsu]|["PHENYTOIN"-tx-12-"PHENYTOIN"-noun-0]|TX|2963/9|D03.383.129.308.432.555.730
00000000|MMI|20.88|Surgical aspects|C0038895|[ftcn]|["operations"-tx-12-"OPERATIONS"-noun-0]|TX|3345/10|x.x.x.x.x.x.x
00000000|MMI|20.11|Order (action)|C1705178|[acty]|["Order"-tx-59-"ORDERS"-verb-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7346/6;2052/5;1820/5;863/5;379/5;214/6|
00000000|MMI|20.11|Order (arrangement)|C1705176|[qlco]|["Order"-tx-59-"ORDERS"-verb-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7346/6;2052/5;1820/5;863/5;379/5;214/6|
00000000|MMI|20.11|Order (document)|C1705175|[inpr]|["Order"-tx-59-"ORDERS"-verb-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7346/6;2052/5;1820/5;863/5;379/5;214/6|
00000000|MMI|20.11|Order (taxonomic)|C1705177|[clas]|["Order"-tx-59-"ORDERS"-verb-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7346/6;2052/5;1820/5;863/5;379/5;214/6|
00000000|MMI|20.11|Permutation|C1882348|[qlco]|["Order"-tx-59-"ORDERS"-verb-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7346/6;2052/5;1820/5;863/5;379/5;214/6|
00000000|MMI|20.11|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-59-"ORDERS"-verb-0,"ORDER"-tx-7-"order"-noun-0,"ORDER"-tx-5-"order"-noun-0,"ORDER"-tx-3-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|7346/6;2052/5;1820/5;863/5;379/5;214/6|
00000000|MMI|19.91|Interaction|C1704675|[ftcn]|["Interaction"-tx-10-"INTERACTION"-noun-0,"Interaction"-tx-9-"INTERACTION"-noun-0,"Interaction"-tx-7-"INTERACTION"-noun-0,"Interaction"-tx-5-"INTERACTION"-noun-0,"Interaction"-tx-3-"INTERACTION"-noun-0]|TX|[2494/11],[2579/11];2299/11;2111/11;1889/11;932/11|
00000000|MMI|19.58|Body Weight|C0005910|[orga]|["Weight"-tx-55-"weight"-noun-0]|TX|6976/6|C23.888.144;E01.370.600.115.100.160.120;E05.041.124.160.750;G07.100.100.160.120;G07.700.320.249.314.120
00000000|MMI|19.58|Chimerin 1|C0067895|[aapp,bacs]|["NC"-tx-26-"NC"-noun-0]|TX|5614/2|D12.644.360.325.150.100.200;D12.776.476.325.150.100.200;D12.776.641.124.200
00000000|MMI|19.53|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-59-"DISCHARGE"-noun-0,"Discharge"-tx-56-"DISCHARGE"-noun-0,"Drainage, NOS"-tx-19-"drainage"-noun-0,"Discharge"-tx-12-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|7336/9;7152/9;4411/8;3022/9;512/9;204/9|
00000000|MMI|19.53|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-59-"DISCHARGE"-noun-0,"Discharge"-tx-56-"DISCHARGE"-noun-0,"Drainage"-tx-19-"drainage"-noun-0,"Discharge"-tx-12-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|7336/9;7152/9;4411/8;3022/9;512/9;204/9|
00000000|MMI|19.43|Insulin Lispro|C0293359|[aapp,horm,phsu]|["Lispro"-tx-48-"lispro"-noun-0]|TX|6735/6|D06.472.699.587.200.400.500;D12.644.548.586.200.400.500
00000000|MMI|19.40|Dilantin|C0699512|[orch,phsu]|["Dilantin"-tx-19-"dilantin"-noun-0]|TX|4755/8|D03.383.129.308.432.555.730
00000000|MMI|19.39|Benadryl|C0700899|[orch,phsu]|["Benadryl"-tx-19-"benadryl"-noun-0]|TX|4649/8|D02.092.471.320;D02.455.426.559.389.115.250
00000000|MMI|19.38|Hermanski-Pudlak Syndrome|C0079504|[cgab,dsyn]|["h s p"-tx-19-"; h p"-adj-0]|TX|4443/3,4468/1|C11.270.040.545.400;C15.378.100.100.515;C15.378.100.685.400;C15.378.140.735.400;C15.378.463.735.400;C16.320.099.515;C16.320.290.040.100.400;C16.320.565.100.102.100.400;C16.320.850.080.100.400;C17.800.621.440.102.100.400;C17.800.827.080.100.400;C18.452.648.100.102.100.400
00000000|MMI|19.36|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-19-"coumadin"-noun-0]|TX|4387/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|19.26|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-56-"treatment"-noun-0,"Therapeutic"-tx-51-"Therapeutic"-adj-0,"Therapeutic"-tx-34-"therapeutic"-adj-0,"Treatment"-tx-12-"Treatment"-noun-0,"Therapeutic"-tx-4-"THERAPEUTIC"-adj-0]|TX|7203/9;6862/11;6052/11;3209/9;[1688/11],[1702/11]|E02
00000000|MMI|19.06|Serious|C0205404|[qlco]|["Serious"-tx-10-"SERIOUS"-adj-0,"Serious"-tx-9-"SERIOUS"-adj-0,"Serious"-tx-7-"SERIOUS"-adj-0,"Serious"-tx-5-"SERIOUS"-adj-0,"Serious"-tx-3-"SERIOUS"-adj-0]|TX|[2486/7],[2571/7];2291/7;2103/7;1881/7;924/7|
00000000|MMI|18.36|VIT gene|C1421454|[gngm]|["VIT"-tx-10-"VIT"-noun-0,"VIT"-tx-9-"VIT"-noun-0,"VIT"-tx-7-"VIT"-noun-0,"VIT"-tx-5-"VIT"-noun-0]|TX|2601/3;2348/3;2133/3;1911/3|
00000000|MMI|18.36|Vitamin B3 Assay|C1142562|[lbpr]|["Niacin"-tx-10-"NIACIN"-noun-0,"Niacin"-tx-9-"NIACIN"-noun-0,"Niacin"-tx-7-"NIACIN"-noun-0,"Niacin"-tx-5-"NIACIN"-noun-0]|TX|2592/6;2339/6;2124/6;1902/6|
00000000|MMI|18.15|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-2-"DOCUSATE SODIUM"-noun-0]|TX|689/15|D02.241.081.337.759.249
00000000|MMI|18.15|Enoxaparin|C0206460|[orch,phsu]|["Enoxaparine"-tx-2-"ENOXAPARIN"-noun-0]|TX|731/10|D09.698.373.400.300.200
00000000|MMI|18.15|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-3-"FUROSEMIDE"-noun-0]|TX|1174/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|18.15|Nexium|C0939400|[orch,phsu]|["Nexium"-tx-51-"nexium"-noun-0]|TX|6884/6|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|17.56|Exanthema|C0015230|[sosy]|["Rashes"-tx-20-"rashes"-noun-1,"RASH"-tx-19-"rash"-noun-0]|TX|4989/6;4774/4|C17.800.257
00000000|MMI|17.29|Hypotension|C0020649|[fndg]|["HYPOTENSION"-tx-12-"hypotension"-noun-0]|TX|[3000/11],[3493/11]|C14.907.514
00000000|MMI|17.27|Diet therapy|C0012159|[hlca]|["Diet"-tx-11-"DIET"-noun-0]|TX|[2667/4],[2734/4]|E02.642.249
00000000|MMI|16.99|Academic Medical Centers|C0000872|[hcro,mnob]|["University Medical Center"-tx-19-"University Medical Center"-noun-0,"University Medical Center"-tx-12-"University Medical Center"-noun-0]|TX|4267/25;3267/25|N02.278.020
00000000|MMI|16.91|Toprol-XL|C0723783|[orch,phsu]|["Toprol XL"-tx-3-"TOPROL XL"-noun-0]|TX|1483/9|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|16.85|Creatine Kinase|C0010287|[aapp,enzy]|["CK"-tx-29-"CK"-noun-0]|TX|5756/2|D08.811.913.696.640.150
00000000|MMI|16.85|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-3-"LASIX"-noun-0]|TX|1166/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|16.85|North Carolina|C0028407|[geoa]|["NC"-tx-26-"NC"-noun-0]|TX|5614/2|Z01.107.567.875.075.475;Z01.107.567.875.750.530
00000000|MMI|16.85|Nuchal Translucency Screen|C1449832|[diap]|["NT"-tx-20-"NT"-noun-0]|TX|4972/2|E01.370.350.850.865.500;E01.370.378.630.865.500
00000000|MMI|16.85|Toprol|C2723006|[phsu]|["Toprol"-tx-19-"Toprol"-noun-0]|TX|4536/6|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|16.78|Colace|C0282139|[orch,phsu]|["Colace"-tx-2-"COLACE"-noun-0]|TX|680/6|D02.241.081.337.759.249
00000000|MMI|16.77|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-3-"meals"-noun-0]|TX|1608/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|16.77|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-19-"NAD"-noun-0]|TX|4832/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|16.75|Carotid Stenosis|C0007282|[dsyn]|["CAROTID STENOSIS"-tx-19-"carotid stenosis"-noun-0]|TX|4449/16|C10.228.140.300.200.360;C14.907.137.230;C14.907.253.123.360
00000000|MMI|16.64|Jaw|C0022359|[bpoc]|["Jaw"-tx-20-"jaw"-noun-0]|TX|4949/3|A02.835.232.781.324.502;A14.521
00000000|MMI|16.08|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-11-"Reason"-noun-0,"Reason"-tx-10-"Reason"-noun-0,"Reason"-tx-8-"Reason"-noun-0,"Reason"-tx-6-"Reason"-noun-0,"Reason"-tx-3-"Reason"-noun-0]|TX|2637/6;2357/6;2160/6;1938/6;988/6|
00000000|MMI|16.00|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-29-"CAD"-noun-0,"CAD"-tx-19-"CAD"-adj-0,"CAD"-tx-19-"CAD"-noun-0,"CAD"-tx-12-"CAD"-noun-0]|TX|5741/3;[4011/3],[4020/3];[4011/3],[4020/3];[3231/3],[3546/3]|
00000000|MMI|15.98|Additional|C1524062|[ftcn]|["Added"-tx-10-"added"-verb-0,"Added"-tx-8-"added"-verb-0,"Added"-tx-6-"added"-verb-0,"Added"-tx-4-"added"-verb-0,"Added"-tx-2-"added"-verb-0]|TX|2451/5;2234/5;2005/5;1768/5;811/5|
00000000|MMI|15.42|Acetaminophen|C0000970|[orch,phsu]|["ACETAMINOPHEN"-tx-2-"ACETAMINOPHEN"-noun-0]|TX|545/13|D02.065.199.092.040
00000000|MMI|15.42|Antibiotics|C0003232|[antb]|["Antibiotics"-tx-12-"antibiotics"-noun-0]|TX|3416/11|D27.505.954.122.085
00000000|MMI|15.42|Blood Glucose|C0005802|[orch]|["Blood Sugar"-tx-49-"Blood sugar"-noun-0]|TX|6746/11|D09.546.359.448.500
00000000|MMI|15.42|Facial Paresis|C0427055|[sosy]|["FACIAL DROOP"-tx-20-"facial droop"-noun-1]|TX|5034/12|C07.465.327;C10.597.622.214;C23.888.592.636.214
00000000|MMI|15.42|Left Bundle-Branch Block|C0023211|[dsyn]|["LBBB"-tx-32-"LBBB"-noun-0]|TX|5985/4|C14.280.067.558.323;C23.550.073.425.100
00000000|MMI|15.42|Milk (body substance)|C0026131|[bdsu]|["MILK"-tx-3-"milk"-noun-0]|TX|1149/4|A12.200.455;G07.203.100.700;G07.203.300.350.525;J02.200.700;J02.500.350.525
00000000|MMI|15.42|Tylenol|C0699142|[orch,phsu]|["Tylenol"-tx-2-"TYLENOL"-noun-0]|TX|535/7|D02.065.199.092.040
00000000|MMI|14.15|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-11-"Low fat DIET"-noun-0]|TX|2681/3,2699/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|14.12|Iodides|C0021966|[inch]|["I-"-tx-29-"I"-noun-0]|TX|5728/1|D01.248.497.158.490;D01.475.410
00000000|MMI|14.12|Lesotho|C0023376|[geoa]|["LT"-tx-3-"lt"-noun-0]|TX|1475/2|Z01.058.290.175.400
00000000|MMI|14.12|New Caledonia|C0027964|[geoa]|["NC"-tx-26-"NC"-noun-0]|TX|5614/2|Z01.639.760.590.620
00000000|MMI|14.08|Dominican Republic|C0013014|[geoa]|["DR"-tx-11-"Dr"-noun-0]|TX|2895/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|13.96|Antacids|C0003138|[phsu]|["Antacid"-tx-3-"antacid"-noun-0]|TX|1158/7|D27.505.519.170;D27.505.954.483.080
00000000|MMI|13.96|Anti-Ulcer Agent|C0003216|[phsu]|["Antacid"-tx-3-"antacid"-noun-0]|TX|1158/7|D27.505.954.483.203
00000000|MMI|13.96|InFed|C0721062|[orch,phsu]|["inf"-tx-20-"inf"-noun-0]|TX|5225/3|D02.691.550.100.500;D09.698.365.272.400
00000000|MMI|13.96|Miconazole|C0025942|[orch,phsu]|["MICONAZOLE"-tx-19-"miconazole"-noun-0]|TX|4732/10|D03.383.129.308.550
00000000|MMI|13.96|Swaziland|C0038983|[geoa]|["SZ"-tx-43-"sz"-noun-0]|TX|6634/2|Z01.058.290.175.795
00000000|MMI|13.93|Anus|C0003461|[bpoc]|["Ano-"-tx-1-"Ano"-noun-0]|TX|276/3|A03.556.124.526.070;A03.556.249.249.070
00000000|MMI|13.92|Bone structure of sacrum|C0036037|[bpoc]|["Sacral"-tx-12-"sacral"-adj-0]|TX|3312/6|A02.835.232.834.717
00000000|MMI|13.92|Hyperlipidemia|C0020473|[dsyn]|["Hyperlipidaemia, NOS"-tx-12-"hyperlipidemia"-noun-0]|TX|3297/14|C18.452.584.500.500
00000000|MMI|13.92|Headache|C0018681|[sosy]|["HEADACHE"-tx-2-"Headache"-noun-0]|TX|579/8|C10.597.617.470;C23.888.592.612.441
00000000|MMI|13.91|Fluorides|C0016327|[inch,phsu]|["F-"-tx-20-"f"-noun-0]|TX|5422/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|13.20|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-38-"3"-integer-0,"3+"-tx-3-"3"-fraction-0,"3+"-tx-1-"3"-fraction-0]|TX|6414/1;[1261/1],[1329/1];181/1|
00000000|MMI|13.20|3+ Score|C2827736|[qnco]|["3+"-tx-38-"3"-integer-0,"3+"-tx-3-"3"-fraction-0,"3+"-tx-1-"3"-fraction-0]|TX|6414/1;[1261/1],[1329/1];181/1|
00000000|MMI|13.20|3+ Score, WHO|C2981702|[clas]|["3+"-tx-38-"3"-integer-0,"3+"-tx-3-"3"-fraction-0,"3+"-tx-1-"3"-fraction-0]|TX|6414/1;[1261/1],[1329/1];181/1|
00000000|MMI|13.20|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-38-"3"-integer-0,"<3"-tx-3-"3"-fraction-0,"<3"-tx-1-"3"-fraction-0]|TX|6414/1;[1261/1],[1329/1];181/1|
00000000|MMI|12.69|ARID1A protein, human|C0675390|[aapp,bacs]|["hELD"-tx-47-"held"-verb-0]|TX|6717/4|x.x.x.x
00000000|MMI|12.69|Anthropological Culture|C0010453|[idcn]|["Cultures"-tx-35-"cultures"-verb-0]|TX|6173/8|I01.076.201.450;I01.880.853.100
00000000|MMI|12.69|Desiccation|C0011682|[npop]|["Dry"-tx-20-"dry"-verb-0]|TX|4982/3|E05.196.335;G02.149.767.530;G02.842.750.530
00000000|MMI|12.69|Dyspnea|C0013404|[sosy]|["SOB"-tx-15-"SOB"-noun-0]|TX|3775/3|C08.618.326;C23.888.852.371
00000000|MMI|12.69|Hypoxia|C0242184|[patf]|["HYPOXIA"-tx-12-"hypoxia"-noun-0]|TX|2990/7|C23.888.852.079
00000000|MMI|12.69|Rales|C0034642|[sosy]|["Crackles"-tx-19-"crackles"-verb-0]|TX|4866/8|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|12.69|Ranitidine Hydrochloride|C0700466|[orch,phsu]|["Ranitidine.HCl"-tx-4-"RANITIDINE HCL"-noun-0]|TX|1644/14|D03.383.312.750
00000000|MMI|12.69|Zantac|C0592278|[orch,phsu]|["Zantac"-tx-4-"ZANTAC"-noun-0]|TX|1635/6|D03.383.312.750
00000000|MMI|12.53|Therapeutic|C0302350|[ftcn]|["Therapeutic"-tx-51-"Therapeutic"-adj-0,"Therapeutic"-tx-34-"therapeutic"-adj-0,"Therapeutic"-tx-4-"THERAPEUTIC"-adj-0]|TX|6862/11;6052/11;[1688/11],[1702/11]|E02
00000000|MMI|12.47|((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1H-fluoren-7-yl)oxy)acetic acid|C0378071|[orch,phsu]|["b-3"-tx-11-"B-3"-adj-0,"b-3"-tx-10-"B-3"-adj-0,"b-3"-tx-8-"B-3"-adj-0,"b-3"-tx-6-"B-3"-adj-0]|TX|2606/3;2353/3;2138/3;1916/3|
00000000|MMI|12.43|Home environment|C0442519|[cnce]|["HOME"-tx-56-"home"-adj-0,"HOME"-tx-47-"Home"-noun-0,"house"-tx-11-"House"-noun-0]|TX|7229/4;6702/4;[2673/5],[2709/5]|
00000000|MMI|12.41|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-56-"dose"-noun-0,"Dose #"-tx-43-"dose"-noun-0,"Dose #"-tx-19-"dose"-noun-0,"Dose number"-tx-3-"Number Doses"-noun-0]|TX|7213/4;6619/4;4352/4;1015/6,1025/5|
00000000|MMI|11.89|Nebulizers|C0027524|[medd]|["Nebuliser"-tx-3-"NEBULIZER"-noun-0]|TX|[1345/9],[1369/9]|E07.605
00000000|MMI|11.78|Emotions|C0013987|[menp]|["feel"-tx-32-"felt"-verb-0,"feel"-tx-14-"felt"-adj-0]|TX|5957/4;3663/4|F01.470
00000000|MMI|11.74|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-3-"Instruction"-noun-0]|TX|[1131/11],[1573/11]|I02.903
00000000|MMI|11.39|Costa Rica|C0010182|[geoa]|["CRI"-tx-41-"CRI"-noun-0]|TX|6552/3|Z01.107.169.238
00000000|MMI|11.39|Coughing|C0010200|[sosy]|["COUGH"-tx-15-"cough"-noun-0]|TX|3713/5|C08.618.248;C23.888.852.293
00000000|MMI|11.33|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-56-"PLAN"-noun-0]|TX|7186/4|C10.228.140.744
00000000|MMI|11.32|Algeria|C0002037|[geoa]|["DZ"-tx-20-"dz"-noun-0]|TX|5127/2|Z01.058.266.104
00000000|MMI|11.32|Pruritus|C0033774|[sosy]|["ITCHING"-tx-19-"itching"-noun-0]|TX|4669/7|C17.800.685;C23.888.885.625
00000000|MMI|11.32|Pressure Ulcer|C0011127|[dsyn]|["Decubitus Ulcer"-tx-12-"decubitus ulcer"-noun-0]|TX|3327/15|C17.800.893.665
00000000|MMI|11.29|Stomach|C0038351|[bpoc]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|1626/7|A03.556.875.875
00000000|MMI|11.28|Hand|C0018563|[bpoc]|["Hands"-tx-15-"hands"-noun-0]|TX|3791/5|A01.378.800.667
00000000|MMI|11.28|Needs|C0027552|[qlco]|["Need"-tx-20-"need"-noun-0]|TX|5336/4|N03.349.380.420;N05.300.450
00000000|MMI|11.26|SDHD protein, human|C1453024|[aapp,enzy]|["SDH"-tx-19-"SDH"-noun-0]|TX|4369/3|x.x.x.x
00000000|MMI|11.23|Endometriosis|C0014175|[dsyn]|["Endo"-tx-46-"Endo"-adj-0]|TX|6691/4|C13.351.500.163
00000000|MMI|11.23|Wheezing|C0043144|[sosy]|["Wheezes"-tx-20-"wheezes"-noun-1]|TX|4899/7|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|11.20|Oxygen|C0030054|[elii,phsu]|["O2"-tx-16-"O2"-noun-0]|TX|3824/2|D01.268.185.550;D01.362.670;x.x.x.x
00000000|MMI|11.20|Sodium|C0037473|[bacs,elii]|["SODIUM"-tx-11-"Sodium"-noun-0]|TX|2747/6|D01.268.549.750;D01.268.557.650;D01.552.528.850;D01.552.547.725;x.x.x.x
00000000|MMI|11.19|Constipation|C0009806|[sosy]|["CONSTIPATION"-tx-2-"Constipation"-noun-0]|TX|667/12|C23.888.821.150
00000000|MMI|11.18|Solomon Islands|C0037623|[geoa]|["BP"-tx-19-"BP"-noun-0]|TX|4810/2|Z01.639.760.590
00000000|MMI|11.17|Burr hole procedure|C0040836|[topp]|["Burr hole"-tx-19-"Burr hole"-noun-0]|TX|4401/9|E04.525.190.840
00000000|MMI|11.17|Family|C0015576|[famg]|["Family"-tx-15-"family"-noun-0]|TX|3801/6|F01.829.263;I01.880.853.150
00000000|MMI|11.17|Diuresis|C0012797|[ortf]|["Diuresis"-tx-12-"diuresis"-noun-0]|TX|3430/8|G08.852.796.241
00000000|MMI|11.17|Panama|C0030266|[geoa]|["PM"-tx-1-"PM"-adj-0]|TX|337/2|Z01.107.169.772
00000000|MMI|11.17|Tachycardia|C0039231|[patf]|["TACHYCARDIA"-tx-37-"tachycardia"-noun-1]|TX|6366/11|C14.280.067.845;C23.550.073.845
00000000|MMI|11.16|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-41-"baseline"-noun-0]|TX|6564/8|x.x.x.x
00000000|MMI|10.01|Resolution|C2699488|[cnce]|["Resolved"-tx-38-"resolved"-adj-0,"Resolve"-tx-37-"resolves"-verb-0,"Resolved"-tx-35-"resolved"-verb-0]|TX|6503/8;6384/8;6103/8|
00000000|MMI|9.95|Complication Aspects|C1171258|[patf]|["complications"-tx-12-"Complications"-noun-0]|TX|3183/13|x.x.x
00000000|MMI|9.95|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-30-"ischemia"-noun-0]|TX|5835/8|C23.550.513
00000000|MMI|9.95|Methods aspects|C0025664|[inpr]|["procedures"-tx-12-"PROCEDURES"-noun-0]|TX|3360/10|x.x.x
00000000|MMI|9.95|Patient Monitoring|C0030695|[hlca]|["monitor"-tx-8-"monitor"-verb-0]|TX|2186/7|E01.370.520
00000000|MMI|9.95|Thinking, function|C0039869|[menp]|["Thought"-tx-30-"thought"-verb-0]|TX|5814/7|F02.463.785
00000000|MMI|9.68|ALYREF gene|C1425988|[gngm]|["REF"-tx-7-"ref"-noun-0,"REF"-tx-5-"ref"-noun-0,"REF"-tx-3-"ref"-noun-0]|TX|2073/3;1851/3;894/3|
00000000|MMI|9.68|M NOS ANTIBODY|C0369637|[aapp,imft]|["M NOS"-tx-56-"M"-noun-0,"M NOS"-tx-4-"M"-noun-0,"M NOS"-tx-2-"M"-noun-0]|TX|7281/1;1807/1;850/1|
00000000|MMI|9.68|M+ (tumor staging)|C0441923|[inpr]|["M+"-tx-56-"M"-noun-0,"M+"-tx-4-"M"-noun-0,"M+"-tx-2-"M"-noun-0]|TX|7281/1;1807/1;850/1|
00000000|MMI|9.67|New LBBB|C3844356|[fndg]|["New LBBB"-tx-37-"New LBBB"-noun-1,"New LBBB"-tx-29-"new LBBB"-noun-0,"New LBBB"-tx-17-"new LBBB"-noun-0]|TX|6343/8;5774/8;3878/8|
00000000|MMI|9.53|Keppra|C0876060|[orch,phsu]|["Keppra"-tx-43-"Keppra"-noun-0,"Keppra"-tx-19-"keppra"-noun-0,"Keppra"-tx-3-"KEPPRA"-noun-0]|TX|6651/6;4632/6;1396/6|
00000000|MMI|9.49|1+|C3816745|[fndg]|["1+"-tx-20-"1"-integer-0,"1+"-tx-4-"1"-integer-0,"1+"-tx-1-"1"-fraction-0]|TX|5466/1;1727/1;321/1|
00000000|MMI|9.49|1+ Score|C2827734|[qnco]|["1+"-tx-20-"1"-integer-0,"1+"-tx-4-"1"-integer-0,"1+"-tx-1-"1"-fraction-0]|TX|5466/1;1727/1;321/1|
00000000|MMI|9.49|1+ Score, WHO|C2981698|[clas]|["1+"-tx-20-"1"-integer-0,"1+"-tx-4-"1"-integer-0,"1+"-tx-1-"1"-fraction-0]|TX|5466/1;1727/1;321/1|
00000000|MMI|9.37|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-27-"CHF"-noun-0,"CONGESTIVE HEART FAILURE"-tx-12-"congestive heart failure"-noun-0,"CONGESTIVE HEART FAILURE"-tx-1-"congestive heart failure"-noun-0]|TX|5675/3;3116/24;89/24|
00000000|MMI|9.35|Elevated|C3163633|[qlco]|["Elevated"-tx-49-"elevated"-verb-0,"Elevated"-tx-31-"elevated"-verb-0,"Elevated"-tx-29-"elevated"-adj-0]|TX|6763/8;5887/8;5747/8|
00000000|MMI|9.35|High|C0205250|[qlco]|["Elevated"-tx-49-"elevated"-verb-0,"Elevated"-tx-31-"elevated"-verb-0,"Elevated"-tx-29-"elevated"-adj-0]|TX|6763/8;5887/8;5747/8|
00000000|MMI|9.34|FABP6 protein, human|C1435727|[aapp,bacs]|["GT"-tx-55-"gt"-noun-0,"GT"-tx-20-"gt"-noun-0,"GT"-tx-16-"gt"-noun-0]|TX|7046/2;5134/2;3837/2|
00000000|MMI|9.24|Unit|C0439148|[qnco]|["Unit"-tx-35-"unit"-adj-0,"UNITS"-tx-3-"UNITS"-noun-0]|TX|6094/4;[1232/5],[1299/5]|
00000000|MMI|9.24|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Unit"-tx-35-"unit"-adj-0,"Units"-tx-3-"UNITS"-noun-0]|TX|6094/4;[1232/5],[1299/5]|
00000000|MMI|9.24|Unit of Measure|C1519795|[qnco]|["Unit"-tx-35-"unit"-adj-0,"Units"-tx-3-"UNITS"-noun-0]|TX|6094/4;[1232/5],[1299/5]|
00000000|MMI|9.24|20%|C3842589|[fndg]|["20%"-tx-19-"20"-integer-0,"20%"-tx-3-"20"-integer-0]|TX|4560/2;[1187/2],[1446/2]|
00000000|MMI|9.23|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-12-"scheduled"-adj-0,"Scheduled"-tx-11-"scheduled"-adj-0]|TX|2923/9;[2846/9],[2883/9]|
00000000|MMI|9.23|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-12-"scheduled"-adj-0,"Scheduled"-tx-11-"scheduled"-adj-0]|TX|2923/9;[2846/9],[2883/9]|
00000000|MMI|9.23|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-12-"scheduled"-adj-0,"Scheduled"-tx-11-"scheduled"-adj-0]|TX|2923/9;[2846/9],[2883/9]|
00000000|MMI|9.21|mg/mg|C1319635|[qnco]|["mg/mg"-tx-3-"MG MG"-noun-0,"mg/mg"-tx-2-"MG MG"-noun-0]|TX|1425/2,1449/2;[565/2,613/2],[747/2,773/2]|
00000000|MMI|9.20|100%|C3817553|[qnco]|["100%"-tx-16-"100"-percentage-0,"100%"-tx-3-"100"-integer-0,"100%"-tx-2-"100"-integer-0]|TX|3848/3;1479/3;707/3|
00000000|MMI|9.19|Discontinued|C1444662|[fndg]|["D/C"-tx-49-"d/c"-noun-0,"D/C"-tx-1-"D/C"-noun-0,"DIS"-tx-1-"DIS"-noun-0]|TX|6794/3;375/3;118/3|
00000000|MMI|9.19|R prime|C2603358|[clna]|["R'"-tx-37-"R"-noun-0,"R'"-tx-20-"R"-adj-0,"R'"-tx-12-"R"-noun-0]|TX|6340/1;5132/1;3411/1|
00000000|MMI|9.19|Right|C0205090|[spco]|["R-"-tx-37-"R"-noun-0,"R-"-tx-20-"R"-adj-0,"R-"-tx-12-"R"-noun-0]|TX|6340/1;5132/1;3411/1|
00000000|MMI|9.16|Code|C0805701|[inpr]|["CODE"-tx-53-"Code"-noun-0,"CODE"-tx-2-"CODE"-noun-0,"CODE"-tx-2-"code"-noun-0]|TX|6895/4;459/4;477/4|
00000000|MMI|9.16|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-53-"Code"-noun-0,"Code"-tx-2-"CODE"-noun-0,"Code"-tx-2-"code"-noun-0]|TX|6895/4;459/4;477/4|
00000000|MMI|9.14|Dosage|C0178602|[qnco]|["DOSE"-tx-56-"dose"-noun-0,"DOSE"-tx-43-"dose"-noun-0,"DOSE"-tx-19-"dose"-noun-0]|TX|7213/4;6619/4;4352/4|
00000000|MMI|9.14|Unit dose|C0869039|[qnco]|["Dose"-tx-56-"dose"-noun-0,"Dose"-tx-43-"dose"-noun-0,"Dose"-tx-19-"dose"-noun-0]|TX|7213/4;6619/4;4352/4|
00000000|MMI|9.11|80%|C3842583|[fndg]|["80%"-tx-19-"80"-integer-0,"80%"-tx-16-"80"-percentage-0,"80%"-tx-2-"80"-integer-0]|TX|4573/2;3831/2;744/2|
00000000|MMI|9.11|contextual factors|C0542559|[ftcn]|["Setting"-tx-38-"setting"-noun-0,"Setting"-tx-37-"setting"-noun-0,"Setting"-tx-19-"setting"-noun-0]|TX|6462/7;6355/7;4376/7|
00000000|MMI|9.11|{Setting}|C1318139|[qnco]|["{Setting}"-tx-38-"setting"-noun-0,"{Setting}"-tx-37-"setting"-noun-0,"{Setting}"-tx-19-"setting"-noun-0]|TX|6462/7;6355/7;4376/7|
00000000|MMI|9.07|Diffuse|C0205219|[qlco]|["DIFFUSE"-tx-20-"diffuse"-adj-0,"DIFFUSE"-tx-19-"diffuse"-adj-0]|TX|[5108/7],[5160/7];4184/7|
00000000|MMI|9.07|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-49-"ed"-noun-0,"ED"-tx-35-"ED"-noun-0,"ED"-tx-18-"ED"-noun-0]|TX|6798/2;6129/2;3968/2|
00000000|MMI|9.02|Appearance|C0700364|[qlco]|["APPEAR"-tx-38-"appears"-verb-0,"APPEAR"-tx-35-"appears"-verb-0]|TX|6495/7;6229/7|
00000000|MMI|9.02|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-12-"DIAGNOSIS"-noun-0]|TX|[2979/9],[3147/9]|E01
00000000|MMI|9.02|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-12-"DIAGNOSIS"-noun-0]|TX|[2979/9],[3147/9]|
00000000|MMI|9.02|Information|C1533716|[idcn]|["INFORMATION"-tx-8-"information"-noun-0,"INFORMATION"-tx-6-"information"-noun-0]|TX|2212/11;1983/11|
00000000|MMI|9.02|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-54-"medications"-noun-0,"Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|6943/11;522/11|
00000000|MMI|9.02|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-54-"medications"-noun-0,"Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|6943/11;522/11|
00000000|MMI|9.02|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-38-"now"-adv-0,"Now"-tx-35-"now"-adv-0]|TX|6491/3;6099/3|
00000000|MMI|9.02|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-5-"QHS"-noun-0,"qHS"-tx-3-"QHS"-noun-0]|TX|1845/3;888/3|
00000000|MMI|9.02|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-54-"medications"-noun-0,"Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|6943/11;522/11|D26
00000000|MMI|9.02|Resolved|C3714811|[fndg]|["Resolved"-tx-38-"resolved"-adj-0,"Resolved"-tx-35-"resolved"-verb-0]|TX|6503/8;6103/8|
00000000|MMI|9.02|Resolved License|C3897700|[ftcn]|["Resolved"-tx-38-"resolved"-adj-0,"Resolved"-tx-35-"resolved"-verb-0]|TX|6503/8;6103/8|
00000000|MMI|9.02|Take|C1515187|[hlca]|["Take"-tx-54-"Take"-verb-0,"Take"-tx-3-"Take"-verb-0]|TX|6934/4;1585/4|
00000000|MMI|9.02|To|C1883351|[qlco]|["To"-tx-55-"to"-adv-0,"To"-tx-30-"to"-adv-0]|TX|7112/2;5822/2|
00000000|MMI|9.02|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-59-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|7346/6;214/6|
00000000|MMI|9.02|physiologic resolution|C1514893|[patf]|["Resolved"-tx-38-"resolved"-adj-0,"Resolved"-tx-35-"resolved"-verb-0]|TX|6503/8;6103/8|
00000000|MMI|8.91|Earwax|C0740486|[bdsu]|["Wax"-tx-14-"waxing"-verb-0]|TX|3684/6|A12.200.147
00000000|MMI|8.65|Cocos (Keeling) Islands|C0009212|[geoa]|["CK"-tx-29-"CK"-noun-0]|TX|5756/2|Z01.639.520
00000000|MMI|8.65|Laboratory|C0022877|[mnob,orgt]|["Lab"-tx-17-"lab"-noun-0]|TX|3896/3|N02.278.487
00000000|MMI|8.65|Sao Tome and Principe|C0036183|[geoa]|["TP"-tx-19-"TP"-noun-0]|TX|4743/2|Z01.639.040
00000000|MMI|8.65|enzymology|C0014445|[ftcn]|["enzymes"-tx-31-"enzymes"-noun-0]|TX|5853/7|x.x.x
00000000|MMI|8.61|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-12-"ALLERGY"-noun-0]|TX|2935/7|H02.403.044
00000000|MMI|8.61|Appointments|C0003629|[idcn]|["Appointment"-tx-11-"APPOINTMENT"-noun-0]|TX|2795/11|N04.452.095
00000000|MMI|8.55|Males|C0086582|[orga]|["MALE"-tx-12-"male"-noun-0]|TX|3536/4|x.x.x
00000000|MMI|8.50|Kidney|C0022646|[bpoc]|["Renal"-tx-41-"Renal"-adj-0]|TX|6544/5|A05.810.453
00000000|MMI|8.50|Switzerland|C0039021|[geoa]|["SZ"-tx-43-"sz"-noun-0]|TX|6634/2|Z01.542.883
00000000|MMI|8.48|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-4-"TAB"-noun-0]|TX|1729/3|D26.255.830
00000000|MMI|8.46|Neurology speciality|C0027855|[bmod]|["NEURO"-tx-43-"Neuro"-adj-0]|TX|6585/5|H02.403.600
00000000|MMI|8.44|Edema|C0013604|[fndg]|["OEDEMA"-tx-35-"edema"-noun-0]|TX|6219/5|C23.888.277
00000000|MMI|8.44|inpatient|C0021562|[podg]|["Inpatient"-tx-20-"inpatient"-noun-0]|TX|5351/9|M01.643.470
00000000|MMI|8.43|Nasal sinus|C0030471|[bsoj]|["Sinus"-tx-20-"sinus"-noun-0]|TX|5285/5|A04.531.621
00000000|MMI|8.43|pathologic fistula|C0016169|[anab]|["Sinus"-tx-20-"sinus"-noun-0]|TX|5285/5|C23.300.575
00000000|MMI|7.22|Infection|C3714514|[patf]|["Infections"-tx-12-"Infections"-noun-0]|TX|3170/10|C01.539
00000000|MMI|6.78|Ischemia co-occurrent and due to increased oxygen demand|C4049375|[dsyn]|["Demand ischemia"-tx-32-"demand ischemia"-noun-0,"Demand ischemia"-tx-20-"demand ischemia"-noun-0]|TX|5967/15;5315/15|
00000000|MMI|6.66|Act Relationship Subset - previous|C1552607|[tmco]|["previous"-tx-8-"Previous"-adj-0,"previous"-tx-6-"Previous"-adj-0]|TX|2194/8;1965/8|
00000000|MMI|6.66|Intravascular line|C0700221|[medd]|["Line"-tx-39-"Line"-noun-0,"Line"-tx-18-"line"-noun-0]|TX|6513/4;3993/4|
00000000|MMI|6.66|Line Specimen|C1550648|[sbst]|["Line"-tx-39-"Line"-noun-0,"Line"-tx-18-"line"-noun-0]|TX|6513/4;3993/4|
00000000|MMI|6.66|Line Unit of Length|C1552960|[qnco]|["Line"-tx-39-"Line"-noun-0,"Line"-tx-18-"line"-noun-0]|TX|6513/4;3993/4|
00000000|MMI|6.66|Linear|C0205132|[spco]|["Line"-tx-39-"Line"-noun-0,"Line"-tx-18-"line"-noun-0]|TX|6513/4;3993/4|
00000000|MMI|6.66|Previous|C0205156|[tmco]|["Previous"-tx-8-"Previous"-adj-0,"Previous"-tx-6-"Previous"-adj-0]|TX|2194/8;1965/8|
00000000|MMI|6.58|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-33-"ASA"-noun-0,"ASA"-tx-19-"ASA"-noun-0]|TX|6008/3;4526/3|
00000000|MMI|6.58|Condition|C0348080|[qlco]|["Condition"-tx-56-"CONDITION"-noun-0,"Condition"-tx-12-"Conditions"-noun-0]|TX|7162/9;3157/10|
00000000|MMI|6.58|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-56-"CONDITION"-noun-0,"Condition"-tx-12-"Conditions"-noun-0]|TX|7162/9;3157/10|
00000000|MMI|6.58|Logical Condition|C1705253|[cnce]|["Condition"-tx-56-"CONDITION"-noun-0,"Condition"-tx-12-"Conditions"-noun-0]|TX|7162/9;3157/10|
00000000|MMI|6.55|Demand (clinical)|C0441516|[topp]|["Demand"-tx-30-"demand"-verb-0,"Demand"-tx-17-"demand"-noun-0]|TX|5828/6;3945/6|
00000000|MMI|6.55|Economic demand|C0699784|[idcn]|["demand"-tx-30-"demand"-verb-0,"demand"-tx-17-"demand"-noun-0]|TX|5828/6;3945/6|
00000000|MMI|6.51|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-16-"called"-verb-0,"Call"-tx-12-"call"-noun-0]|TX|3813/6;3512/4|
00000000|MMI|6.51|Decision|C0679006|[menp]|["Call"-tx-16-"called"-verb-0,"Call"-tx-12-"call"-noun-0]|TX|3813/6;3512/4|
00000000|MMI|6.46|4+ Answer to question|C3838679|[fndg]|["4+"-tx-40-"4"-integer-0,"4+"-tx-13-"4"-fraction-0]|TX|6541/1;3628/1|
00000000|MMI|6.42|sacral ulcer|C0748470|[dsyn]|["sacral ulcer"-tx-19-"sacral ulcer"-noun-0,"sacral ulcer"-tx-12-"sacral ulcer"-noun-0]|TX|4489/6,4505/5;3312/6,3337/5|
00000000|MMI|6.40|23|C0450348|[qnco]|["23"-tx-3-"23"-fraction-0]|TX|[1263/2],[1331/2]|
00000000|MMI|6.40|Nebulizer Device Component|C1709156|[mnob]|["Nebulizer"-tx-3-"NEBULIZER"-noun-0]|TX|[1345/9],[1369/9]|
00000000|MMI|6.38|Furosemide 20 MG|C0986198|[clnd]|["Furosemide 20 MG"-tx-36-"20 mg Lasix"-noun-0,"Furosemide 20 MG"-tx-20-"Lasix 20 mg"-noun-0]|TX|6283/11;5447/11|
00000000|MMI|6.32|Admission activity|C0809949|[hlca]|["Admission"-tx-49-"admission"-noun-0,"Admission"-tx-12-"Admission"-noun-0]|TX|6779/9;3079/9|
00000000|MMI|6.31|+2|C0740116|[qnco]|["+2"-tx-31-"2"-integer-0,"+2"-tx-11-"2"-integer-0]|TX|5934/1;2740/1|
00000000|MMI|6.31|2+|C3833492|[fndg]|["2+"-tx-31-"2"-integer-0,"2+"-tx-11-"2"-integer-0]|TX|5934/1;2740/1|
00000000|MMI|6.31|2+ Score|C2827735|[qnco]|["2+"-tx-31-"2"-integer-0,"2+"-tx-11-"2"-integer-0]|TX|5934/1;2740/1|
00000000|MMI|6.31|2+ Score, WHO|C2981700|[clas]|["2+"-tx-31-"2"-integer-0,"2+"-tx-11-"2"-integer-0]|TX|5934/1;2740/1|
00000000|MMI|6.31|Hypotension Adverse Event|C3163620|[fndg]|["Hypotension"-tx-12-"hypotension"-noun-0]|TX|[3000/11],[3493/11]|
00000000|MMI|6.30|Plain chest X-ray|C0039985|[diap]|["cxr"-tx-27-"CXR"-noun-0,"cxr"-tx-20-"CXR"-noun-0]|TX|5618/3;5102/3|
00000000|MMI|6.30|Rate|C1521828|[qnco]|["Rate"-tx-37-"rate"-noun-0,"Rate"-tx-32-"rate"-adj-0]|TX|6408/4;5990/4|
00000000|MMI|6.30|Rating (action)|C0871208|[acty]|["Rate"-tx-37-"rate"-noun-0,"Rate"-tx-32-"rate"-adj-0]|TX|6408/4;5990/4|
00000000|MMI|6.29|Basal Diet|C2983588|[food]|["DIET"-tx-11-"DIET"-noun-0]|TX|[2667/4],[2734/4]|
00000000|MMI|6.29|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-11-"DIET"-noun-0]|TX|[2667/4],[2734/4]|
00000000|MMI|6.29|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-11-"DIET"-noun-0]|TX|[2667/4],[2734/4]|
00000000|MMI|6.28|Conditional|C1701901|[qlco]|["Dependent"-tx-32-"dependent"-adj-0,"Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|5995/9;340/10|
00000000|MMI|6.28|Summary (document)|C1706244|[inpr]|["Summary"-tx-56-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|7246/7;404/7|
00000000|MMI|6.28|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-56-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|7246/7;404/7|
00000000|MMI|6.28|10 - 29%|C3842507|[fndg]|["10 - 29%"-tx-4-"10/29"-fraction-0,"10 - 29%"-tx-2-"10/29"-fraction-0]|TX|1777/5;820/5|
00000000|MMI|6.26|Today|C0310367|[antb,orch]|["Today"-tx-3-"Today"-noun-0]|TX|[1253/5],[1321/5]|
00000000|MMI|6.26|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-3-"Today"-noun-0]|TX|[1253/5],[1321/5]|
00000000|MMI|6.26|+5|C0728893|[qnco]|["+5"-tx-55-"5"-integer-0,"+5"-tx-42-"5"-integer-0]|TX|7069/1;6582/1|
00000000|MMI|6.26|>5|C0439084|[qnco]|[">5"-tx-55-"5"-integer-0,">5"-tx-42-"5"-integer-0]|TX|7069/1;6582/1|
00000000|MMI|6.26|Card (document)|C3275277|[inpr]|["Card"-tx-32-"cards"-noun-0,"Card"-tx-20-"Cards"-noun-0]|TX|5947/5;5307/5|
00000000|MMI|6.26|Requirement|C1514873|[ftcn]|["Required"-tx-18-"required"-adj-0,"Required"-tx-3-"Required"-verb-0]|TX|3971/8;1031/8|
00000000|MMI|6.25|Non-ST Elevation Myocardial Infarction by ECG Finding|C3537184|[fndg]|["NSTEMI"-tx-19-"NSTEMI"-noun-0]|TX|[4062/6],[4132/6]|
00000000|MMI|6.25|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-3-"Instruction"-noun-0]|TX|[1131/11],[1573/11]|
00000000|MMI|6.25|Instructions|C1442085|[idcn]|["instruction"-tx-3-"Instruction"-noun-0]|TX|[1131/11],[1573/11]|
00000000|MMI|6.24|Removed|C0849355|[qlco]|["Removed"-tx-39-"removed"-verb-0,"Out"-tx-12-"out"-adv-0]|TX|6518/7;3517/3|
00000000|MMI|6.23|Decreased|C0205216|[qnco]|["Decreased"-tx-37-"decreased"-adj-0,"Decreased"-tx-31-"decreased"-verb-0]|TX|6398/9;5913/9|
00000000|MMI|6.23|Decreasing|C0442797|[qlco]|["decreased"-tx-37-"decreased"-adj-0,"decreased"-tx-31-"decreased"-verb-0]|TX|6398/9;5913/9|
00000000|MMI|6.23|Reduced|C0392756|[qlco]|["Decreased"-tx-37-"decreased"-adj-0,"Decreased"-tx-31-"decreased"-verb-0]|TX|6398/9;5913/9|
00000000|MMI|6.20|Component (part)|C1705248|[cnce]|["Component"-tx-35-"component"-noun-0,"Component"-tx-27-"component"-noun-0]|TX|6195/9;5662/9|
00000000|MMI|6.20|Component object|C0449432|[mnob]|["Component"-tx-35-"component"-noun-0,"Component"-tx-27-"component"-noun-0]|TX|6195/9;5662/9|
00000000|MMI|6.19|Pounds|C0439219|[qnco]|["lbs"-tx-55-"lbs"-noun-0]|TX|[7052/3],[7071/3]|
00000000|MMI|6.19|liquid-based cytology (procedure)|C3161851|[lbpr]|["LBS"-tx-55-"lbs"-noun-0]|TX|[7052/3],[7071/3]|
00000000|MMI|6.19|LDB3 gene|C1423674|[gngm]|["CYPHER"-tx-19-"cypher"-noun-0]|TX|[4080/6],[4150/6]|
00000000|MMI|6.18|Send (transmission)|C1519246|[ftcn]|["Send"-tx-49-"sending"-noun-0,"Send"-tx-36-"send"-verb-0]|TX|6815/7;6275/4|
00000000|MMI|6.18|Waxes|C0043076|[bodm]|["WAX"-tx-14-"waxing"-verb-0]|TX|3684/6|D10.945
00000000|MMI|6.17|/40|C0439509|[tmco]|["/40"-tx-19-"40"-integer-0,"/40"-tx-10-"40"-integer-0]|TX|4608/2;2409/2|
00000000|MMI|6.17|40%|C3842587|[qnco]|["40%"-tx-19-"40"-integer-0,"40%"-tx-10-"40"-integer-0]|TX|4608/2;2409/2|
00000000|MMI|6.16|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-46-"DM"-noun-0,"DM"-tx-12-"DM"-noun-0]|TX|6698/2;3228/2|
00000000|MMI|6.14|30%|C3842588|[fndg]|["30%"-tx-11-"30"-integer-0,"30%"-tx-3-"30"-integer-0]|TX|2843/2;1057/2|
00000000|MMI|6.14|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-59-"END"-noun-0,"Stop"-tx-20-"stop"-noun-0]|TX|7329/3;5363/4|
00000000|MMI|6.13|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-56-"Stable"-adj-0,"Stable"-tx-37-"stable"-adj-0]|TX|7173/6;6305/6|
00000000|MMI|6.13|Stable status|C0205360|[qlco]|["STABLE"-tx-56-"Stable"-adj-0,"STABLE"-tx-37-"stable"-adj-0]|TX|7173/6;6305/6|
00000000|MMI|6.12|Negation|C1518422|[ftcn]|["Not"-tx-20-"not"-adv-0,"Not"-tx-12-"NOT"-adv-0]|TX|5008/3;3402/3|
00000000|MMI|6.12|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-49-"d/c"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|6794/3;375/3|
00000000|MMI|6.11|Pulmonary ventilator management|C1315068|[hlca]|["PULM"-tx-35-"pulm"-adj-0,"PULM"-tx-19-"Pulm"-adj-0]|TX|6214/4;4859/4|
00000000|MMI|6.11|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-43-"h/o"-noun-0,"h o"-tx-12-"h/o"-noun-0]|TX|6593/3;3604/3|
00000000|MMI|6.10|Biospecimen Domain|C3814390|[inpr]|["BS"-tx-20-"BS"-noun-0]|TX|[4882/2],[4954/2]|
00000000|MMI|6.10|Black Swiss Mouse|C4049076|[mamm]|["BS"-tx-20-"BS"-noun-0]|TX|[4882/2],[4954/2]|
00000000|MMI|6.10|Bug Search Subtest (WPPSI-IV)|C4050217|[inpr]|["BS"-tx-20-"BS"-noun-0]|TX|[4882/2],[4954/2]|
00000000|MMI|6.09|97|C0439073|[inpr]|["97"-tx-19-"97"-percentage-0,"97"-tx-16-"97"-percentage-0]|TX|4825/2;3841/2|
00000000|MMI|6.09|>97|C0439082|[qnco]|[">97"-tx-19-"97"-percentage-0,">97"-tx-16-"97"-percentage-0]|TX|4825/2;3841/2|
00000000|MMI|6.08|Stress|C0038435|[fndg]|["Stress"-tx-20-"stress"-noun-1]|TX|[5344/6],[5393/6]|
00000000|MMI|6.07|Ischemic|C0475224|[ftcn]|["Ischemic"-tx-19-"ischemic"-adj-0,"Ischemic"-tx-12-"ischemic"-adj-0]|TX|4308/8;3578/8|
00000000|MMI|6.05|Numerous|C0439064|[qnco]|["MULTIPLE"-tx-43-"multiple"-adj-0,"MULTIPLE"-tx-19-"multiple"-adj-0]|TX|6597/8;4329/8|
00000000|MMI|6.05|ASAH1 gene|C1412573|[gngm]|["AC"-tx-49-"AC"-noun-0,"AC"-tx-3-"AC"-noun-0]|TX|6838/2;1241/2|
00000000|MMI|6.05|ASAH1 wt Allele|C3539770|[gngm]|["AC"-tx-49-"AC"-noun-0,"AC"-tx-3-"AC"-noun-0]|TX|6838/2;1241/2|
00000000|MMI|6.05|Micronization|C3829074|[lbpr]|["Micronize"-tx-10-"MICRONIZED"-noun-0,"Micronize"-tx-3-"MICRONIZED"-noun-0]|TX|2521/10;959/10|
00000000|MMI|6.05|Full|C0443225|[qlco]|["Full"-tx-53-"FULL"-adj-0,"Full"-tx-2-"Full"-adj-0]|TX|6902/4;472/4|
00000000|MMI|6.05|RAX gene|C1425688|[gngm]|["RX"-tx-43-"Rx"-noun-0,"RX"-tx-19-"Rx"-noun-0]|TX|6616/2;4349/2|
00000000|MMI|6.05|Rx therapy|C2709207|[topp]|["Rx"-tx-43-"Rx"-noun-0,"Rx"-tx-19-"Rx"-noun-0]|TX|6616/2;4349/2|
00000000|MMI|6.03|Administration procedure|C1533734|[topp]|["Treatment"-tx-56-"treatment"-noun-0,"Treatment"-tx-12-"Treatment"-noun-0]|TX|7203/9;3209/9|
00000000|MMI|6.03|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-56-"treatment"-noun-0,"Treatment"-tx-12-"Treatment"-noun-0]|TX|7203/9;3209/9|
00000000|MMI|6.03|Treating|C1522326|[ftcn]|["Treatment"-tx-56-"treatment"-noun-0,"Treatment"-tx-12-"Treatment"-noun-0]|TX|7203/9;3209/9|
00000000|MMI|6.03|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-56-"treatment"-noun-0,"TREATMENT"-tx-12-"Treatment"-noun-0]|TX|7203/9;3209/9|
00000000|MMI|6.03|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-56-"treatment"-noun-0,"treatment"-tx-12-"Treatment"-noun-0]|TX|7203/9;3209/9|
00000000|MMI|6.02|Mechanical Methods|C0443254|[ftcn]|["Mechanical"-tx-20-"mechanical"-adj-0]|TX|[4926/10],[5257/10]|
00000000|MMI|6.02|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-16-"sat"-noun-0,"SAT"-tx-11-"sat"-noun-0]|TX|3827/3;2694/3|
00000000|MMI|6.02|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-16-"sat"-noun-0,"SAT"-tx-11-"sat"-noun-0]|TX|3827/3;2694/3|
00000000|MMI|6.01|House (environment)|C2003847|[mnob]|["House"-tx-11-"House"-noun-0]|TX|[2673/5],[2709/5]|
00000000|MMI|6.01|70%|C3842584|[fndg]|["70%"-tx-19-"70"-percentage-0]|TX|[4090/2],[4116/2]|
00000000|MMI|5.98|Beginning|C0439659|[tmco]|["Start"-tx-3-"Starting"-adj-0]|TX|[1244/8],[1312/8]|
00000000|MMI|5.97|BBS9 wt Allele|C3889128|[gngm]|["D1"-tx-19-"D1"-noun-0]|TX|[4127/2],[4160/2]|
00000000|MMI|5.97|LMOD1 gene|C1416886|[gngm]|["D1"-tx-19-"D1"-noun-0]|TX|[4127/2],[4160/2]|
00000000|MMI|5.96|Shortened|C1282927|[qlco]|["short"-tx-28-"short"-adj-0,"brief"-tx-12-"BRIEF"-adj-0]|TX|5690/5;3439/5|
00000000|MMI|5.96|Echo (insect)|C1655045|[euka]|["Echo"-tx-37-"echo"-noun-0,"Echo"-tx-20-"Echo"-noun-0]|TX|6335/4;5183/4|
00000000|MMI|5.92|Enzymes|C0014442|[enzy,orch]|["ENZYMES"-tx-31-"enzymes"-noun-0]|TX|5853/7|D08.811
00000000|MMI|5.88|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-12-"ALLERGY"-noun-0]|TX|2935/7|C20.543
00000000|MMI|5.88|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-12-"ALLERGY"-noun-0]|TX|2935/7|C20.543
00000000|MMI|5.69|Drainage procedure|C0013103|[topp]|["Drainage"-tx-19-"drainage"-noun-0]|TX|4411/8|E02.309;E04.237
00000000|MMI|4.49|ARID1A wt Allele|C2985160|[gngm]|["hELD"-tx-47-"held"-verb-0]|TX|6717/4|
00000000|MMI|4.49|Acetaminophen [EPC]|C2917659|[phsu]|["Acetaminophen"-tx-2-"ACETAMINOPHEN"-noun-0]|TX|545/13|
00000000|MMI|4.49|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-12-"OPERATIONS"-noun-0]|TX|3345/10|
00000000|MMI|4.49|Add - instruction imperative|C1883712|[ftcn]|["Add"-tx-20-"add"-verb-0]|TX|5443/3|
00000000|MMI|4.49|Additional comments|C1830770|[fndg]|["Additional comments"-tx-54-"ADDITIONAL COMMENTS"-noun-0]|TX|6913/19|
00000000|MMI|4.49|Affecting|C0392760|[ftcn]|["Affecting"-tx-12-"affecting"-verb-0]|TX|3199/9|
00000000|MMI|4.49|Anicteric|C0205180|[fndg]|["Anicteric"-tx-19-"anicteric"-adj-0]|TX|4838/9|
00000000|MMI|4.49|Antibiotic throat preparations|C3540706|[antb]|["Antibiotics"-tx-12-"antibiotics"-noun-0]|TX|3416/11|
00000000|MMI|4.49|Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C3540707|[antb]|["Antibiotics"-tx-12-"antibiotics"-noun-0]|TX|3416/11|
00000000|MMI|4.49|Antibiotics for systemic use|C3540704|[antb]|["Antibiotics"-tx-12-"antibiotics"-noun-0]|TX|3416/11|
00000000|MMI|4.49|Antibiotics, Gynecological|C3540708|[antb]|["Antibiotics"-tx-12-"antibiotics"-noun-0]|TX|3416/11|
00000000|MMI|4.49|Antibiotics, ophthalmologic|C3540710|[antb]|["Antibiotics"-tx-12-"antibiotics"-noun-0]|TX|3416/11|
00000000|MMI|4.49|Antifungal Antibiotics, Topical|C3540705|[antb]|["Antibiotics"-tx-12-"antibiotics"-noun-0]|TX|3416/11|
00000000|MMI|4.49|Approximate|C0332232|[qlco]|["Approximate"-tx-3-"approximate"-adj-0]|TX|1042/11|
00000000|MMI|4.49|Apyrexial|C0277797|[fndg]|["Afebrile"-tx-25-"Afebrile"-adj-0]|TX|5598/8|
00000000|MMI|4.49|Awake|C0234422|[fndg]|["Awake"-tx-20-"awake"-adj-1]|TX|4996/5|
00000000|MMI|4.49|Basilar Rales|C0240859|[fndg]|["Crackles"-tx-19-"crackles"-verb-0]|TX|4866/8|
00000000|MMI|4.49|Biomedical Monitors|C0181904|[medd]|["Monitor"-tx-8-"monitor"-verb-0]|TX|2186/7|
00000000|MMI|4.49|Blood glucose measurement|C0392201|[lbpr]|["Blood Sugar"-tx-49-"Blood sugar"-noun-0]|TX|6746/11|
00000000|MMI|4.49|C-Circle|C3538933|[celc]|["CC"-tx-12-"cc"-noun-0]|TX|3472/2|
00000000|MMI|4.49|Cleared by|C0521097|[ftcn]|["cleared"-tx-27-"cleared"-verb-0]|TX|5622/7|
00000000|MMI|4.49|Communication Contact|C1705415|[idcn]|["Contact"-tx-55-"contact"-verb-0]|TX|7089/7|
00000000|MMI|4.49|Complication|C0009566|[patf]|["Complications"-tx-12-"Complications"-noun-0]|TX|3183/13|
00000000|MMI|4.49|Contact with|C0332158|[ftcn]|["contact"-tx-55-"contact"-verb-0]|TX|7089/7|
00000000|MMI|4.49|Continuous|C0549178|[idcn]|["Continue"-tx-56-"Continue"-verb-0]|TX|7194/8|
00000000|MMI|4.49|Cow's milk|C0349374|[food]|["Milk"-tx-3-"milk"-noun-0]|TX|1149/4|
00000000|MMI|4.49|Cultural aspects|C0220814|[ftcn]|["culture"-tx-35-"cultures"-verb-0]|TX|6173/8|
00000000|MMI|4.49|Dec.|C3843930|[fndg]|["Dec."-tx-19-"dec"-noun-0]|TX|4877/3|
00000000|MMI|4.49|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|165/14|
00000000|MMI|4.49|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|165/14|
00000000|MMI|4.49|Doctor of Philosophy|C1512022|[inpr]|["Ph.D."-tx-58-"PH.D"-noun-0]|TX|7293/4|
00000000|MMI|4.49|Dry|C0205222|[qlco]|["Dry"-tx-20-"dry"-verb-0]|TX|4982/3|
00000000|MMI|4.49|Dryness (characteristic)|C1512080|[qlco]|["Dry"-tx-20-"dry"-verb-0]|TX|4982/3|
00000000|MMI|4.49|Electrocardiogram: left bundle branch block (finding)|C0344420|[lbtr]|["LBBB"-tx-32-"LBBB"-noun-0]|TX|5985/4|
00000000|MMI|4.49|Elia|C3623712|[euka]|["Elia"-tx-1-"ELIA"-noun-0]|TX|228/4|
00000000|MMI|4.49|Extended Release Dosage Form|C1707968|[bodm]|["Extended Release"-tx-3-"EXTENDED RELEASE"-adj-0]|TX|1516/16|
00000000|MMI|4.49|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-12-"OPERATIONS"-noun-0]|TX|3345/10|
00000000|MMI|4.49|Held - activity status|C1948036|[idcn]|["held"-tx-47-"held"-verb-0]|TX|6717/4|
00000000|MMI|4.49|Hold (action)|C1948035|[acty]|["Hold"-tx-3-"HOLD"-verb-0]|TX|1461/4|
00000000|MMI|4.49|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-3-"HOLD"-verb-0]|TX|1461/4|
00000000|MMI|4.49|Hypoxia Adverse Event|C1963140|[fndg]|["HYPOXIA"-tx-12-"hypoxia"-noun-0]|TX|2990/7|
00000000|MMI|4.49|Identifier|C0600091|[inpr]|["ID"-tx-21-"ID"-noun-0]|TX|5469/2|
00000000|MMI|4.49|Immune diffusion|C1441613|[lbpr]|["ID"-tx-21-"ID"-noun-0]|TX|5469/2|
00000000|MMI|4.49|Increasing|C0442808|[ftcn]|["Increasing"-tx-55-"increasing"-noun-0]|TX|7124/10|
00000000|MMI|4.49|Indicated|C1444656|[fndg]|["Indicated"-tx-20-"indicated"-verb-0]|TX|5410/9|
00000000|MMI|4.49|Initially|C0205265|[tmco]|["Initially"-tx-30-"Initially"-adv-0]|TX|5804/9|
00000000|MMI|4.49|Insulin, Aspart, Human|C0123677|[aapp,horm,phsu]|["INSULIN ASPART"-tx-3-"INSULIN ASPART"-noun-0]|TX|1212/14|
00000000|MMI|4.49|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-12-"PROCEDURES"-noun-0]|TX|3360/10|
00000000|MMI|4.49|Involvement with|C1314939|[ftcn]|["Affecting"-tx-12-"affecting"-verb-0]|TX|3199/9|
00000000|MMI|4.49|Laboratory culture|C0430400|[lbpr]|["Culture"-tx-35-"cultures"-verb-0]|TX|6173/8|
00000000|MMI|4.49|Levetiracetam|C0377265|[orch,phsu]|["LEVETIRACETAM"-tx-3-"LEVETIRACETAM"-noun-0]|TX|1405/13|
00000000|MMI|4.49|Medical History|C0262926|[fndg]|["PMH"-tx-19-"PMH"-noun-0]|TX|4006/3|
00000000|MMI|4.49|Microbial culture (procedure)|C2242979|[lbpr]|["Culture"-tx-35-"cultures"-verb-0]|TX|6173/8|
00000000|MMI|4.49|Milk - dietary|C2825079|[food]|["MILK"-tx-3-"milk"-noun-0]|TX|1149/4|
00000000|MMI|4.49|Milk Specimen|C0444318|[sbst]|["Milk"-tx-3-"milk"-noun-0]|TX|1149/4|
00000000|MMI|4.49|Monitor Device Component|C1704646|[mnob]|["Monitor"-tx-8-"monitor"-verb-0]|TX|2186/7|
00000000|MMI|4.49|Monitor, occupation|C1521743|[prog]|["Monitor"-tx-8-"monitor"-verb-0]|TX|2186/7|
00000000|MMI|4.49|Monitoring Device|C0596972|[medd]|["Monitor"-tx-8-"monitor"-verb-0]|TX|2186/7|
00000000|MMI|4.49|Moving|C0560560|[orgf]|["Moving"-tx-20-"moving"-verb-0]|TX|5068/6|
00000000|MMI|4.49|Negative|C0205160|[qlco]|["Negative"-tx-35-"negative"-noun-0]|TX|6182/8|
00000000|MMI|4.49|Negative - answer|C3853545|[qlco]|["Negative"-tx-35-"negative"-noun-0]|TX|6182/8|
00000000|MMI|4.49|Negative Charge|C2825491|[qlco]|["Negative"-tx-35-"negative"-noun-0]|TX|6182/8|
00000000|MMI|4.49|Negative Finding|C1513916|[fndg]|["NEGATIVE"-tx-35-"negative"-noun-0]|TX|6182/8|
00000000|MMI|4.49|Negative Number|C2825415|[cnce]|["Negative"-tx-35-"negative"-noun-0]|TX|6182/8|
00000000|MMI|4.49|On admission|C0457453|[tmco]|["On admission"-tx-19-"On admission"-adj-0]|TX|4783/12|
00000000|MMI|4.49|P Blood group antibodies|C0369773|[aapp,imft]|["P NOS"-tx-35-"P"-noun-0]|TX|6081/1|
00000000|MMI|4.49|P prime|C2603361|[clna]|["P'"-tx-35-"P"-noun-0]|TX|6081/1|
00000000|MMI|4.49|Per Liter|C3642217|[qnco]|["/L"-tx-20-"L"-noun-0]|TX|5137/1|
00000000|MMI|4.49|Personal Contact|C3812666|[acty]|["Contact"-tx-55-"contact"-verb-0]|TX|7089/7|
00000000|MMI|4.49|Phenytoin sodium|C0237417|[orch,phsu]|["PHENYTOIN SODIUM"-tx-12-"PHENYTOIN SODIUM"-noun-0]|TX|2944/16|
00000000|MMI|4.49|Physician:Identifier:Point in time:^Patient:Nominal|C0804815|[clna]|["Physician"-tx-55-"physician"-noun-0]|TX|7102/9|
00000000|MMI|4.49|Preventive monitoring|C0150369|[hlca]|["monitor"-tx-8-"monitor"-verb-0]|TX|2186/7|
00000000|MMI|4.49|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-12-"PROCEDURES"-noun-0]|TX|3360/10|
00000000|MMI|4.49|Recent|C0332185|[tmco]|["Recent"-tx-13-"Recent"-adj-0]|TX|3615/6|
00000000|MMI|4.49|Rigor - Temperature-associated observation|C0424790|[sosy]|["RIGORS"-tx-15-"rigors"-noun-0]|TX|3721/6|
00000000|MMI|4.49|S prime|C2603362|[clna]|["S'"-tx-11-"("-noun-0]|TX|2806/1|
00000000|MMI|4.49|Scintimammography|C2985547|[diap]|["MBI"-tx-19-"MBI"-noun-0]|TX|4679/3|
00000000|MMI|4.49|Sundowning|C1142436|[mobd]|["sun downing"-tx-44-"Sundowning"-noun-0]|TX|6659/10|
00000000|MMI|4.49|Very|C0442824|[qlco]|["Very"-tx-49-"very"-adv-0]|TX|6758/4|
00000000|MMI|4.49|Very Much|C2984081|[qlco]|["Very"-tx-49-"very"-adv-0]|TX|6758/4|
00000000|MMI|4.49|Warmer, device|C0184348|[medd]|["Warm"-tx-20-"warm"-adj-0]|TX|4975/4|
00000000|MMI|4.49|antibiotics, intestinal|C3540709|[antb]|["Antibiotics"-tx-12-"antibiotics"-noun-0]|TX|3416/11|
00000000|MMI|4.49|atorvastatin|C0286651|[orch,phsu]|["ATORVASTATIN"-tx-10-"ATORVASTATIN"-noun-0]|TX|2394/12|
00000000|MMI|4.49|consider|C0750591|[idcn]|["consider"-tx-55-"consider"-verb-0]|TX|7115/8|
00000000|MMI|4.49|contact person|C0337611|[popg]|["Contact"-tx-55-"contact"-verb-0]|TX|7089/7|
00000000|MMI|4.49|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-3-"HOLD"-verb-0]|TX|1461/4|
00000000|MMI|4.49|liter/second|C0439394|[qnco]|["l's"-tx-20-"L"-noun-0]|TX|5137/1|
00000000|MMI|4.49|metoprolol succinate|C0724633|[orch,phsu]|["METOPROLOL SUCCINATE"-tx-3-"METOPROLOL SUCCINATE"-noun-0]|TX|1495/20|
00000000|MMI|4.49|per second|C0565930|[qnco]|["/s"-tx-11-"("-noun-0]|TX|2806/1|
00000000|MMI|4.49|prescribed|C0278329|[hlca]|["Prescribed"-tx-54-"prescribed"-verb-0]|TX|6958/10|
00000000|MMI|4.49|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-12-"TREATMENTS/PROCEDURES"-noun-0]|TX|3378/21|
00000000|MMI|4.49|upper case letter ell|C1706495|[inpr]|["L-"-tx-20-"L"-noun-0]|TX|5137/1|
00000000|MMI|4.49|warming process|C0687712|[npop]|["warm"-tx-20-"warm"-adj-0]|TX|4975/4|
00000000|MMI|3.57|Salty food|C0453862|[food]|["High salt food"-tx-55-"high salt foods"-noun-0]|TX|6999/15|
00000000|MMI|3.48|Furosemide:Mass:Pt:Dose:Qn|C0366492|[clna]|["Furosemide Dose"-tx-55-"lasix dose"-noun-0]|TX|7140/10|
00000000|MMI|3.44|Place|C0442504|[spco]|["Place"-tx-18-"placed"-verb-0]|TX|3998/6|
00000000|MMI|3.44|Place - dosing instruction imperative|C1704765|[ftcn]|["Place"-tx-18-"placed"-verb-0]|TX|3998/6|
00000000|MMI|3.44|Show|C1547282|[anim]|["Show"-tx-17-"showed"-verb-0]|TX|3871/6|
00000000|MMI|3.44|Side|C0441987|[spco]|["Side"-tx-20-"sided"-verb-0]|TX|5028/5|
00000000|MMI|3.44|put - instruction imperative|C1882509|[acty]|["Place"-tx-18-"placed"-verb-0]|TX|3998/6|
00000000|MMI|3.28|Difficulty speaking|C1527347|[fndg]|["Difficulty speaking"-tx-15-"difficulty speaking"-noun-0]|TX|3730/10,3749/8|
00000000|MMI|3.27|Source of infection|C0449426|[fndg]|["Source of infection"-tx-35-"source of infection"-noun-0]|TX|6146/19|
00000000|MMI|3.24|CHRFAM7A gene|C1423729|[gngm]|["D-10"-tx-24-"D 10"-noun-0]|TX|5548/1,5560/2|
00000000|MMI|3.21|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-12-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|3012/9,3032/9|
00000000|MMI|3.21|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-12-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|3012/9,3032/9|
00000000|MMI|3.19|50%|C3842586|[fndg]|["50%"-tx-19-"50"-integer-0]|TX|4710/2|
00000000|MMI|3.19|<50|C3843766|[fndg]|["<50"-tx-19-"50"-integer-0]|TX|4710/2|
00000000|MMI|3.19|At|C1516077|[spco]|["At"-tx-56-"at"-adj-0]|TX|7226/2|
00000000|MMI|3.19|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|417/9|
00000000|MMI|3.19|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|417/9|
00000000|MMI|3.19|Blood group antibody I|C0221138|[aapp,imft]|["I NOS"-tx-29-"I"-noun-0]|TX|5728/1|
00000000|MMI|3.19|CD44 wt Allele|C1707101|[gngm]|["IN"-tx-35-"in"-adj-0]|TX|6091/2|
00000000|MMI|3.19|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-41-"CRI"-noun-0]|TX|6552/3|
00000000|MMI|3.19|Cough Adverse Event|C1961131|[fndg]|["Cough"-tx-15-"cough"-noun-0]|TX|3713/5|
00000000|MMI|3.19|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-41-"CRI"-noun-0]|TX|6552/3|
00000000|MMI|3.19|Dependent - ability|C0851827|[qlco]|["Dependent"-tx-32-"dependent"-adj-0]|TX|5995/9|
00000000|MMI|3.19|ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS|C3540048|[enzy,phsu]|["ENZYMES"-tx-31-"enzymes"-noun-0]|TX|5853/7|
00000000|MMI|3.19|Enzyme Unit|C1880519|[qnco]|["Unit"-tx-35-"unit"-adj-0]|TX|6094/4|
00000000|MMI|3.19|Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|C3540772|[enzy,phsu]|["Enzymes"-tx-31-"enzymes"-noun-0]|TX|5853/7|
00000000|MMI|3.19|Enzymes for ALIMENTARY TRACT AND METABOLISM|C3542456|[enzy,phsu]|["Enzymes"-tx-31-"enzymes"-noun-0]|TX|5853/7|
00000000|MMI|3.19|Enzymes, antithrombotic|C3541394|[enzy,phsu]|["Enzymes"-tx-31-"enzymes"-noun-0]|TX|5853/7|
00000000|MMI|3.19|Enzymes, hematological|C3540017|[enzy,phsu]|["Enzymes"-tx-31-"enzymes"-noun-0]|TX|5853/7|
00000000|MMI|3.19|Enzymes, peripheral vasodilators|C3540790|[enzy,phsu]|["Enzymes"-tx-31-"enzymes"-noun-0]|TX|5853/7|
00000000|MMI|3.19|Fine - adjective|C0205232|[qlco]|["Fine"-tx-14-"fine"-adj-0]|TX|3668/4|
00000000|MMI|3.19|GATM wt Allele|C4049625|[gngm]|["AT"-tx-56-"at"-adj-0]|TX|7226/2|
00000000|MMI|3.19|Importance Weight|C1705104|[idcn]|["Weight"-tx-55-"weight"-noun-0]|TX|6976/6|
00000000|MMI|3.19|Legal fine|C0687757|[rnlw]|["fine"-tx-14-"fine"-adj-0]|TX|3668/4|
00000000|MMI|3.19|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-3-"lt"-noun-0]|TX|1475/2|
00000000|MMI|3.19|NT5E wt Allele|C3889152|[gngm]|["NT"-tx-20-"NT"-noun-0]|TX|4972/2|
00000000|MMI|3.19|No treatment required for|C0332126|[qlco]|["NT"-tx-20-"NT"-noun-0]|TX|4972/2|
00000000|MMI|3.19|Present|C0150312|[qnco]|["In"-tx-35-"in"-adj-0]|TX|6091/2|
00000000|MMI|3.19|RNH1 gene|C1826843|[gngm]|["CRI"-tx-41-"CRI"-noun-0]|TX|6552/3|
00000000|MMI|3.19|Remaining|C1527428|[qlco]|["Remaining"-tx-31-"remaining"-noun-0]|TX|5877/9|
00000000|MMI|3.19|S1|C3715215|[fndg]|["S1"-tx-20-"S1"-noun-1]|TX|4937/2|
00000000|MMI|3.19|SS, Rat Strain|C2699257|[mamm]|["SS"-tx-48-"SS"-noun-0]|TX|6742/2|
00000000|MMI|3.19|Status|C0449438|[qlco]|["Status"-tx-2-"STATUS"-noun-0]|TX|464/6|
00000000|MMI|3.19|Storage Unit|C1704753|[mnob]|["Unit"-tx-35-"unit"-adj-0]|TX|6094/4|
00000000|MMI|3.19|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-3-"lt"-noun-0]|TX|1475/2|
00000000|MMI|3.19|Subject Status Domain|C3891295|[inpr]|["SS"-tx-48-"SS"-noun-0]|TX|6742/2|
00000000|MMI|3.19|TMPO wt Allele|C3541334|[gngm]|["TP"-tx-19-"TP"-noun-0]|TX|4743/2|
00000000|MMI|3.19|Testicular Cancer Serum Markers Test Result S1|C3814877|[lbtr]|["S1"-tx-20-"S1"-noun-1]|TX|4937/2|
00000000|MMI|3.19|Tyrosine Nitration|C4050156|[moft]|["NT"-tx-20-"NT"-noun-0]|TX|4972/2|
00000000|MMI|3.19|Walls of a building|C0677535|[mnob]|["Wall"-tx-20-"wall"-noun-0]|TX|5229/4|
00000000|MMI|3.19|Weighing patient|C1305866|[diap]|["weight"-tx-55-"weight"-noun-0]|TX|6976/6|
00000000|MMI|3.19|Weight|C0043100|[qnco]|["WEIGHT"-tx-55-"weight"-noun-0]|TX|6976/6|
00000000|MMI|3.19|Within|C0332285|[spco]|["In"-tx-35-"in"-adj-0]|TX|6091/2|
00000000|MMI|3.19|dependent|C3244310|[ftcn]|["dependent"-tx-32-"dependent"-adj-0]|TX|5995/9|
00000000|MMI|3.19|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-12-"DISCHARGE DIAGNOSIS"-noun-0]|TX|3022/19|
00000000|MMI|3.16|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|150/13|
00000000|MMI|3.15|Entered|C1521975|[qlco]|["Entered"-tx-56-"ENTERED"-verb-0]|TX|7254/7|
00000000|MMI|3.15|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|124/14|
00000000|MMI|3.15|Agent|C0450442|[chvf]|["Agent"-tx-19-"agents"-noun-0]|TX|4226/6|
00000000|MMI|3.15|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-12-"ALLERGY"-noun-0]|TX|2935/7|
00000000|MMI|3.15|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-12-"ALLERGY"-noun-0]|TX|2935/7|
00000000|MMI|3.15|Anatomical segmentation|C0441635|[spco]|["SEGMENT"-tx-20-"segment"-noun-0]|TX|5247/7|
00000000|MMI|3.15|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|124/14|
00000000|MMI|3.15|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-11-"Dr"-noun-0]|TX|2895/2|
00000000|MMI|3.15|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-11-"Dr"-noun-0]|TX|2895/2|
00000000|MMI|3.15|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|482/11|
00000000|MMI|3.15|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|482/11|
00000000|MMI|3.15|Doctor - Title|C2348314|[cnce]|["Dr."-tx-11-"Dr"-noun-0]|TX|2895/2|
00000000|MMI|3.15|Flexion, function|C0231452|[ortf]|["Flexed"-tx-20-"flexed"-noun-0]|TX|5059/6|
00000000|MMI|3.15|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-19-"meds"-noun-0]|TX|4521/4|
00000000|MMI|3.15|Out (direction)|C0439787|[spco]|["Out"-tx-12-"out"-adv-0]|TX|3517/3|
00000000|MMI|3.15|Pharmacologic Substance|C1254351|[phsu]|["Agent"-tx-19-"agents"-noun-0]|TX|4226/6|
00000000|MMI|3.15|Precursor B-cell lymphoblastic leukemia|C1292769|[neop]|["c all"-tx-12-"call"-noun-0]|TX|3512/4|
00000000|MMI|3.15|Protocol Agent|C1521826|[inpr]|["Agent"-tx-19-"agents"-noun-0]|TX|4226/6|
00000000|MMI|3.15|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-12-"ALLERGY"-noun-0]|TX|2935/7|
00000000|MMI|3.15|Speaking (activity)|C0234856|[dora]|["Speaking"-tx-15-"speaking"-noun-0]|TX|3749/8|
00000000|MMI|3.13|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-11-"ACTIVITY"-noun-0]|TX|2754/8|
00000000|MMI|3.13|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|286/7|
00000000|MMI|3.13|Active|C0205177|[ftcn]|["Activity"-tx-11-"ACTIVITY"-noun-0]|TX|2754/8|
00000000|MMI|3.13|Activities|C0441655|[acty]|["ACTIVITY"-tx-11-"ACTIVITY"-noun-0]|TX|2754/8|
00000000|MMI|3.13|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-11-"ACTIVITY"-noun-0]|TX|2754/8|
00000000|MMI|3.13|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-11-"ACTIVITY"-noun-0]|TX|2754/8|
00000000|MMI|3.13|Percent Activity|C0439167|[qnco]|["% Activity"-tx-11-"ACTIVITY"-noun-0]|TX|2754/8|
00000000|MMI|3.13|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-11-"ACTIVITY"-noun-0]|TX|2754/8|
00000000|MMI|3.13|Planned|C1301732|[ftcn]|["Plan"-tx-56-"PLAN"-noun-0]|TX|7186/4|
00000000|MMI|3.13|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|286/7|
00000000|MMI|3.13|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|286/7|
00000000|MMI|3.13|Treatment Plan|C0599880|[inpr]|["Plan"-tx-56-"PLAN"-noun-0]|TX|7186/4|
00000000|MMI|3.12|Multivitamin preparation|C0301532|[orch,phsu,vita]|["Multivitamin"-tx-4-"MULTIVITAMIN"-noun-0]|TX|1675/12|
00000000|MMI|3.12|Dose number|C1115464|[qnco]|["Dose number"-tx-3-"Number Doses"-noun-0]|TX|1015/6,1025/5|
00000000|MMI|3.12|Specimen Source Codes - Ulcer, Decubitus|C1546597|[inpr]|["Ulcer, Decubitus"-tx-12-"decubitus ulcer"-noun-0]|TX|3327/15|
00000000|MMI|3.12|September|C3828193|[tmco]|["September"-tx-11-"September"-noun-0]|TX|2813/9|
00000000|MMI|3.11|Pressure ulcer of sacral region|C0558159|[patf]|["Sacral Decubitus Ulcers"-tx-12-"sacral decubitus ulcer"-noun-0]|TX|3312/6,3327/15|
00000000|MMI|3.11|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.11|Room|C1547703|[spco]|["Room"-tx-1-"Room"-noun-0]|TX|266/4|
00000000|MMI|3.11|End|C0444930|[spco]|["End"-tx-59-"END"-noun-0]|TX|7329/3|
00000000|MMI|3.11|Fever symptoms (finding)|C0424755|[fndg]|["Fever"-tx-15-"fever"-noun-0]|TX|3760/5|
00000000|MMI|3.11|Responsible to|C1273518|[fndg]|["Responsible"-tx-12-"Responsible"-adj-0]|TX|3043/11|
00000000|MMI|3.11|Saphenous vein graft|C0729538|[bpoc]|["SVG"-tx-19-"SVG"-noun-0]|TX|4047/3|
00000000|MMI|3.11|Scalable Vector Graphics|C2827658|[lang]|["SVG"-tx-19-"SVG"-noun-0]|TX|4047/3|
00000000|MMI|3.11|Decubitus direction|C0442303|[spco]|["Decubitus"-tx-12-"decubitus"-noun-0]|TX|3327/9|
00000000|MMI|3.11|Recumbent body position|C0444334|[spco]|["DECUBITUS"-tx-12-"decubitus"-noun-0]|TX|3327/9|
00000000|MMI|3.09|TDGF1P2 gene|C3469967|[gngm]|["CR-2"-tx-41-"Cr 2"-noun-0]|TX|6558/2,6575/1|
00000000|MMI|3.09|TDGF1P5 gene|C3469970|[gngm]|["CR-5"-tx-41-"Cr 5"-noun-0]|TX|6558/2,6579/1|
00000000|MMI|3.09|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-3-"empty"-adj-0]|TX|1620/5|
00000000|MMI|3.09|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|1626/7|
00000000|MMI|3.09|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|1626/7|
00000000|MMI|3.09|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|1626/7|
00000000|MMI|3.08|% volume (qualifier value)|C1690016|[qlco]|["% volume"-tx-35-"volume"-noun-0]|TX|6259/6|
00000000|MMI|3.08|Changed status|C0443172|[qnco]|["changes"-tx-37-"changes"-noun-0]|TX|6324/7|
00000000|MMI|3.08|Changing|C0392747|[ftcn]|["changes"-tx-37-"changes"-noun-0]|TX|6324/7|
00000000|MMI|3.08|Hypotensive|C0857353|[patf]|["Hypotensive"-tx-18-"Hypotensive"-adj-0]|TX|3953/11|
00000000|MMI|3.08|Male Gender, Self Report|C1706180|[qlco]|["Male"-tx-12-"male"-noun-0]|TX|3536/4|
00000000|MMI|3.08|Male Phenotype|C1706428|[qlco]|["Male"-tx-12-"male"-noun-0]|TX|3536/4|
00000000|MMI|3.08|Male, Self-Reported|C1706429|[orga]|["Male"-tx-12-"male"-noun-0]|TX|3536/4|
00000000|MMI|3.08|Patient need for (contextual qualifier)|C0686904|[ftcn]|["need"-tx-20-"need"-noun-0]|TX|5336/4|
00000000|MMI|3.08|Pixel|C1709558|[cnce]|["PIXEL"-tx-19-"pixel"-noun-0]|TX|4107/5|
00000000|MMI|3.08|Structure of middle lobe of lung|C0225757|[bpoc]|["RML"-tx-13-"RML"-noun-0]|TX|3637/3|
00000000|MMI|3.08|Volume|C0449468|[qnco]|["*Volume"-tx-35-"volume"-noun-0]|TX|6259/6|
00000000|MMI|3.08|Volume (publication)|C1705102|[inpr]|["Volume"-tx-35-"volume"-noun-0]|TX|6259/6|
00000000|MMI|3.08|Volume Measurement|C2700258|[lbpr]|["Volume"-tx-35-"volume"-noun-0]|TX|6259/6|
00000000|MMI|3.08|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-12-"RESUME"-noun-0]|TX|3445/6|
00000000|MMI|3.08|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-12-"RESUME"-noun-0]|TX|3445/6|
00000000|MMI|3.08|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-0]|TX|388/4|
00000000|MMI|3.08|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-12-"RESUME"-noun-0]|TX|3445/6|
00000000|MMI|3.07|Course|C0750729|[tmco]|["Course"-tx-28-"course"-noun-0]|TX|5702/6|
00000000|MMI|3.06|2/day|C3843641|[fndg]|["2/day"-tx-13-"2 day"-noun-0]|TX|3647/5|
00000000|MMI|3.06|> 2/day|C3843640|[fndg]|["> 2/day"-tx-13-"2 day"-noun-0]|TX|3647/5|
00000000|MMI|3.06|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-11-"FOLLOW UP"-adj-0]|TX|2785/9|
00000000|MMI|3.06|Difficulty walking|C0311394|[fndg]|["DIFFICULTY WALKING"-tx-15-"difficulty walking"-noun-0]|TX|3730/18|
00000000|MMI|3.06|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-11-"FOLLOW UP"-adj-0]|TX|2785/9|
00000000|MMI|3.06|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-11-"FOLLOW UP"-adj-0]|TX|2785/9|
00000000|MMI|3.06|Zantac 150|C0724451|[orch,phsu]|["Zantac 150"-tx-19-"zantac 150"-noun-0]|TX|4715/10|
00000000|MMI|3.06|follow-up|C1522577|[hlca]|["Follow Up"-tx-11-"FOLLOW UP"-adj-0]|TX|2785/9|
00000000|MMI|3.03|Antacid Effects|C1383090|[phsf]|["Antacid"-tx-3-"antacid"-noun-0]|TX|1158/7|
00000000|MMI|3.03|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-29-"CV"-noun-0]|TX|5723/2|
00000000|MMI|3.03|Causing|C0678227|[ftcn]|["Causing"-tx-12-"Causing"-adj-0]|TX|3071/7|
00000000|MMI|3.03|Checking (action)|C1283174|[acty]|["Check"-tx-55-"Check"-noun-0]|TX|6970/5|
00000000|MMI|3.03|Cheque|C1555524|[mnob]|["Cheque"-tx-55-"Check"-noun-0]|TX|6970/5|
00000000|MMI|3.03|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|198/5|
00000000|MMI|3.03|Distant|C0443203|[spco]|["DISTANT"-tx-20-"distant"-adj-0]|TX|4913/7|
00000000|MMI|3.03|Empiric|C1880496|[qlco]|["Empiric"-tx-23-"empiric"-adj-0]|TX|5501/7|
00000000|MMI|3.03|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|198/5|
00000000|MMI|3.03|Extensive|C0205231|[qlco]|["Extensive"-tx-29-"Extensive"-adj-0]|TX|5731/9|
00000000|MMI|3.03|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|198/5|
00000000|MMI|3.03|Four|C0205450|[qnco]|["Four"-tx-20-"four"-word_numeral-0]|TX|5079/4|
00000000|MMI|3.03|GIF gene|C1415066|[gngm]|["INF"-tx-20-"inf"-noun-0]|TX|5225/3|
00000000|MMI|3.03|Increase|C0442805|[ftcn]|["Increased"-tx-15-"Increased"-adj-0]|TX|3703/9|
00000000|MMI|3.03|Increased|C0205217|[qnco]|["Increased"-tx-15-"Increased"-adj-0]|TX|3703/9|
00000000|MMI|3.03|MANEA gene|C1427293|[gngm]|["ENDO"-tx-46-"Endo"-adj-0]|TX|6691/4|
00000000|MMI|3.03|SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME|C3542022|[dsyn]|["SOFT"-tx-20-"soft"-adj-0]|TX|4967/4|
00000000|MMI|3.03|Soft|C0205358|[qlco]|["Soft"-tx-20-"soft"-adj-0]|TX|4967/4|
00000000|MMI|3.03|Syringe Dosing Unit|C1706071|[qnco]|["SZ"-tx-43-"sz"-noun-0]|TX|6634/2|
00000000|MMI|3.03|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|413/3|
00000000|MMI|3.03|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|413/3|
00000000|MMI|3.03|Zyprexa|C0527258|[orch,phsu]|["ZyPREXA"-tx-44-"zyprexa"-noun-0]|TX|6675/7|
00000000|MMI|3.03|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-56-"dictated"-adj-0]|TX|7237/8|
00000000|MMI|3.03|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-56-"dictated"-adj-0]|TX|7237/8|
00000000|MMI|3.03|Left elbow region structure|C0230354|[blor]|["L elbow"-tx-20-"L forearm"-noun-0]|TX|5049/9|
00000000|MMI|3.02|T 98|C0215604|[orch,phsu]|["T 98"-tx-19-"T 98"-noun-0]|TX|4797/1,4813/2|
00000000|MMI|3.01|Akinetic|C0233568|[ftcn]|["Akinetic"-tx-20-"akinesis"-noun-0]|TX|5204/8|
00000000|MMI|3.01|Brya|C1085821|[plnt]|["Brya"-tx-56-"BRYON"-noun-0]|TX|7275/5|
00000000|MMI|3.01|trend|C1521798|[tmco]|["Trend"-tx-31-"Trended"-adj-0]|TX|5845/7|
00000000|MMI|3.01|0/5|C0444499|[qnco]|["0/5"-tx-3-"0.5"-real_number-0]|TX|1381/3|
00000000|MMI|3.01|Apical|C0205111|[spco]|["APICAL"-tx-20-"apical"-adj-0]|TX|5236/6|
00000000|MMI|3.01|Clear|C2963144|[qlco]|["Clear"-tx-19-"clear"-adj-0]|TX|4853/5|
00000000|MMI|3.01|Desquam|C2917495|[phsu]|["Desquam"-tx-19-"desquam"-noun-0]|TX|4766/7|
00000000|MMI|3.01|L-Type Amino Acid Transporter|C4049852|[aapp,bacs]|["LAT"-tx-20-"lat"-noun-0]|TX|5243/3|
00000000|MMI|3.01|Methylcytosine Dioxygenase TET1|C2987138|[aapp,enzy]|["LCX"-tx-19-"LCx"-noun-0]|TX|4192/3|
00000000|MMI|3.01|Negative Surgical Margin|C1709157|[fndg]|["Clear"-tx-19-"clear"-adj-0]|TX|4853/5|
00000000|MMI|3.01|PDHX gene|C1427500|[gngm]|["proX"-tx-19-"prox"-noun-0]|TX|4094/4|
00000000|MMI|3.01|Stop (Instruction Imperative)|C1947925|[acty]|["Stop"-tx-20-"stop"-noun-0]|TX|5363/4|
00000000|MMI|3.01|TET1 gene|C1428863|[gngm]|["LCX"-tx-19-"LCx"-noun-0]|TX|4192/3|
00000000|MMI|3.01|TET1 wt Allele|C2987137|[gngm]|["LCX"-tx-19-"LCx"-noun-0]|TX|4192/3|
00000000|MMI|3.01|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-4-"TAB"-noun-0]|TX|1729/3|
00000000|MMI|3.01|With laterality|C0332304|[spco]|["LAT"-tx-20-"lat"-noun-0]|TX|5243/3|
00000000|MMI|3.01|cooperative|C0679729|[orgt]|["cooperative"-tx-20-"cooperative"-adj-0]|TX|5012/11|
00000000|MMI|3.01|tracking|C0546881|[spco]|["Tracking"-tx-20-"tracking"-adj-0]|TX|5368/8|
00000000|MMI|3.00|ADI1 gene|C1826411|[gngm]|["ARD"-tx-1-"Ard"-noun-0]|TX|272/3|
00000000|MMI|3.00|Primary|C0205225|[qlco]|["Principal"-tx-12-"PRINCIPAL"-adj-0]|TX|3012/9|
00000000|MMI|3.00|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-17-"likely"-adj-0]|TX|3933/6|
00000000|MMI|3.00|Probably|C0750492|[idcn]|["Likely"-tx-17-"likely"-adj-0]|TX|3933/6|
00000000|MMI|3.00|Sodium Cation|C0597484|[elii]|["Sodium+"-tx-11-"Sodium"-noun-0]|TX|2747/6|
00000000|MMI|3.00|Sodium Drug Class|C3714642|[phsu]|["SODIUM"-tx-11-"Sodium"-noun-0]|TX|2747/6|
00000000|MMI|3.00|Sodium supplements|C3541959|[phsu]|["Sodium"-tx-11-"Sodium"-noun-0]|TX|2747/6|
00000000|MMI|3.00|Teaching principal|C0401925|[prog]|["Principal"-tx-12-"PRINCIPAL"-adj-0]|TX|3012/9|
00000000|MMI|3.00|acireductone dioxygenase [iron(II)-requiring] activity|C1817569|[moft]|["ARD'"-tx-1-"Ard"-noun-0]|TX|272/3|
00000000|MMI|3.00|gram|C0439208|[qnco]|["GRAM"-tx-11-"gram"-noun-0]|TX|2742/4|
00000000|MMI|3.00|Blue lips|C0240194|[sosy]|["Blue lips"-tx-15-"blue lips"-noun-0]|TX|3781/9|
00000000|MMI|3.00|One week|C4082116|[tmco]|["One week"-tx-55-"one week"-noun-0]|TX|7078/8|
00000000|MMI|2.99|Alert|C3665546|[ftcn]|["Alert"-tx-10-"Alert"-adj-0]|TX|2424/5|
00000000|MMI|2.99|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-10-"Alert"-adj-0]|TX|2424/5|
00000000|MMI|2.99|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-11-"ADA"-noun-0]|TX|2717/3|
00000000|MMI|2.99|CA8 gene|C1413051|[gngm]|["CALS"-tx-11-"cals"-noun-0]|TX|2726/4|
00000000|MMI|2.99|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-10-"Alert"-adj-0]|TX|2424/5|
00000000|MMI|2.99|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|118/3|
00000000|MMI|2.99|Every evening|C0585330|[tmco]|["QPM"-tx-3-"QPM"-noun-0]|TX|1308/3|
00000000|MMI|2.99|Four times daily|C0585291|[tmco]|["QID"-tx-3-"QID"-adv-0]|TX|1392/3|
00000000|MMI|2.99|Genus Ada|C1060325|[plnt]|["Ada"-tx-11-"ADA"-noun-0]|TX|2717/3|
00000000|MMI|2.99|NEB gene|C1417656|[gngm]|["NEB"-tx-3-"NEB"-noun-0]|TX|1388/3|
00000000|MMI|2.99|Nebulizer solution|C1300458|[bodm]|["Neb"-tx-3-"NEB"-noun-0]|TX|1388/3|
00000000|MMI|2.99|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-11-"cals"-noun-0]|TX|2726/4|
00000000|MMI|2.99|Once a day, in the evening|C1275568|[tmco]|["qPM"-tx-3-"QPM"-noun-0]|TX|1308/3|
00000000|MMI|2.99|Study Day|C2826182|[tmco]|["DY"-tx-11-"dy"-noun-0]|TX|2731/2|
00000000|MMI|2.99|kilocalorie|C0439259|[qnco]|["Cal"-tx-11-"cals"-noun-0]|TX|2726/4|
00000000|MMI|2.99|2 Days|C1442455|[tmco]|["2 Days"-tx-55-"2 days"-noun-0]|TX|7050/1,7061/4|
00000000|MMI|2.99|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-11-"chol"-noun-0]|TX|2685/4|
00000000|MMI|2.99|Constipation Adverse Event|C1963087|[fndg]|["Constipation"-tx-2-"Constipation"-noun-0]|TX|667/12|
00000000|MMI|2.99|71|C0450389|[inpr]|["71"-tx-1-"71"-integer-0]|TX|249/2|
00000000|MMI|2.99|Field|C1521738|[cnce]|["Field"-tx-1-"Field"-noun-0]|TX|257/5|
00000000|MMI|2.99|Field's stain|C0440042|[irda]|["Field's"-tx-1-"Field"-noun-0]|TX|257/5|
00000000|MMI|2.99|Force Field|C2349184|[cnce]|["Field"-tx-1-"Field"-noun-0]|TX|257/5|
00000000|MMI|2.99|HCRT wt Allele|C3811761|[gngm]|["OX"-tx-1-"Ox"-noun-0]|TX|263/2|
00000000|MMI|2.99|In the Field|C3539073|[spco]|["FIELD"-tx-1-"Field"-noun-0]|TX|257/5|
00000000|MMI|2.99|Knowledge Field|C2346620|[cnce]|["Field"-tx-1-"Field"-noun-0]|TX|257/5|
00000000|MMI|2.99|Ox (organism)|C0300971|[mamm]|["Ox"-tx-1-"Ox"-noun-0]|TX|263/2|
00000000|MMI|2.99|Base|C0178499|[chvf]|["bases"-tx-20-"bases"-noun-0]|TX|4888/5|
00000000|MMI|2.99|Hospital course|C0489547|[fndg]|["Hospital course"-tx-12-"HOSPITAL COURSE"-noun-1]|TX|3455/15|
00000000|MMI|2.99|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-12-"HOSPITAL COURSE"-noun-0]|TX|3455/15|
00000000|MMI|2.99|Room of building - Study|C0557651|[mnob]|["Study"-tx-12-"Study"-noun-0]|TX|3061/5|
00000000|MMI|2.99|Study|C2603343|[resa]|["Study"-tx-12-"Study"-noun-0]|TX|3061/5|
00000000|MMI|2.99|Unit dose - Base|C1626935|[qnco]|["Bases"-tx-20-"bases"-noun-0]|TX|4888/5|
00000000|MMI|2.99|Missing Value Reason|C1709044|[qlco]|["MVR"-tx-12-"MVR"-noun-0]|TX|3293/3|
00000000|MMI|2.99|Serum lipids high (finding)|C0428465|[fndg]|["Hyperlipidemia"-tx-12-"hyperlipidemia"-noun-0]|TX|3297/14|
00000000|MMI|2.99|Every four hours|C0585324|[tmco]|["Q4H"-tx-2-"Q4H"-noun-0]|TX|571/3|
00000000|MMI|2.99|HP gene|C1415692|[gngm]|["Bp"-tx-19-"BP"-noun-0]|TX|4810/2|
00000000|MMI|2.99|HP wt Allele|C1708288|[gngm]|["BP"-tx-19-"BP"-noun-0]|TX|4810/2|
00000000|MMI|2.98|ANTICOAGULATION (finding)|C2919015|[fndg]|["ANTICOAGULATION"-tx-38-"anticoagulation"-noun-0]|TX|6473/15|
00000000|MMI|2.98|Anticoagulation Therapy|C0003281|[topp]|["anticoagulation"-tx-38-"anticoagulation"-noun-0]|TX|6473/15|
00000000|MMI|2.98|Decreased Coagulation Activity [PE]|C3537050|[phsf]|["Anticoagulation"-tx-38-"anticoagulation"-noun-0]|TX|6473/15|
00000000|MMI|2.98|Entire jaw region|C1273020|[blor]|["Jaw"-tx-20-"jaw"-noun-0]|TX|4949/3|
00000000|MMI|2.98|More|C0205172|[ftcn]|["More"-tx-27-"more"-adv-0]|TX|5657/4|
00000000|MMI|2.98|Negative Regulation of Coagulation|C2917212|[phsf]|["Anticoagulation"-tx-38-"anticoagulation"-noun-0]|TX|6473/15|
00000000|MMI|2.98|Possible|C0332149|[qlco]|["Possible"-tx-24-"possible"-adj-0]|TX|5577/8|
00000000|MMI|2.98|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-24-"possible"-adj-0]|TX|5577/8|
00000000|MMI|2.98|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-24-"possible"-adj-0]|TX|5577/8|
00000000|MMI|2.98|Day 7|C3842672|[fndg]|["Day 7"-tx-28-"7 day"-noun-0]|TX|5696/5|
00000000|MMI|2.98|1800s|C0681738|[tmco]|["1800s"-tx-11-"1800"-integer-0]|TX|2721/4|
00000000|MMI|2.97|Anatomic Site|C1515974|[blor]|["Site"-tx-38-"site"-noun-0]|TX|6454/4|
00000000|MMI|2.97|Body Fluids and Substances|C1521806|[tisu]|["Fluids"-tx-18-"fluids"-noun-0]|TX|3980/6|
00000000|MMI|2.97|CDR2 gene|C1413296|[gngm]|["Yo"-tx-12-"yo"-noun-0]|TX|3533/2|
00000000|MMI|2.97|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-35-"edema"-noun-0]|TX|6219/5|
00000000|MMI|2.97|Family (taxonomic)|C1704727|[cnce]|["Family"-tx-15-"family"-noun-0]|TX|3801/6|
00000000|MMI|2.97|Flash|C0262485|[diap]|["Flash"-tx-35-"flash"-noun-0]|TX|6208/5|
00000000|MMI|2.97|Light Sources, Flash|C0181637|[medd]|["flash"-tx-35-"flash"-noun-0]|TX|6208/5|
00000000|MMI|2.97|Liquid substance|C0302908|[sbst]|["fluids"-tx-18-"fluids"-noun-0]|TX|3980/6|
00000000|MMI|2.97|Patient Class - Inpatient|C1549404|[idcn]|["Inpatient"-tx-20-"inpatient"-noun-0]|TX|5351/9|
00000000|MMI|2.97|Referral category - Inpatient|C1548438|[idcn]|["Inpatient"-tx-20-"inpatient"-noun-0]|TX|5351/9|
00000000|MMI|2.97|Site|C0205145|[spco]|["Site"-tx-38-"site"-noun-0]|TX|6454/4|
00000000|MMI|2.97|Slight (qualifier value)|C2937276|[qlco]|["Slightly"-tx-35-"slightly"-adv-0]|TX|6250/8|
00000000|MMI|2.97|Slightly (qualifier value)|C0750482|[qlco]|["Slightly"-tx-35-"slightly"-adv-0]|TX|6250/8|
00000000|MMI|2.97|Study Site|C2825164|[spco]|["Site"-tx-38-"site"-noun-0]|TX|6454/4|
00000000|MMI|2.97|Subclavicular approach|C0589488|[spco]|["Subclavian"-tx-38-"subclavian"-adj-0]|TX|6443/10|
00000000|MMI|2.97|Trephine hole|C1265713|[acab]|["Burr Hole"-tx-19-"Burr hole"-noun-0]|TX|4401/9|
00000000|MMI|2.97|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-12-"BRIEF"-adj-0]|TX|3439/5|
00000000|MMI|2.97|Brief|C1879313|[tmco]|["Brief"-tx-12-"BRIEF"-adj-0]|TX|3439/5|
00000000|MMI|2.97|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-1-"PM"-adj-0]|TX|337/2|
00000000|MMI|2.97|New|C0205314|[qlco]|["NEW"-tx-19-"new"-adj-0]|TX|4146/3|
00000000|MMI|2.97|Restenosis|C0333186|[acab]|["Restenosis"-tx-19-"restenosis"-noun-0]|TX|4171/10|
00000000|MMI|2.97|Tachycardia by ECG Finding|C3827868|[fndg]|["TACHYCARDIA"-tx-37-"tachycardia"-noun-1]|TX|6366/11|
00000000|MMI|2.97|Baseline|C1442488|[qnco]|["Baseline"-tx-41-"baseline"-noun-0]|TX|6564/8|
00000000|MMI|2.97|Minute volume|C0428679|[fndg]|["MV"-tx-20-"MV"-noun-0]|TX|5268/2|
00000000|MMI|2.97|Sinus - general anatomical term|C1305231|[bsoj]|["SINUS"-tx-20-"sinus"-noun-0]|TX|5285/5|
00000000|MMI|2.96|Complete|C0205197|[qlco]|["COMPLETED"-tx-28-"Completed"-adj-0]|TX|5680/9|
00000000|MMI|2.96|Short|C1806781|[qnco]|["Short"-tx-28-"short"-adj-0]|TX|5690/5|
00000000|MMI|2.96|Short Value|C2350002|[qnco]|["Short"-tx-28-"short"-adj-0]|TX|5690/5|
00000000|MMI|2.96|completed - RoleLinkStatus|C3854010|[idcn]|["completed"-tx-28-"Completed"-adj-0]|TX|5680/9|
00000000|MMI|2.96|Cea (insect genus)|C3463961|[euka]|["Cea"-tx-19-"CEA"-noun-0]|TX|4472/3|
00000000|MMI|2.96|Supernumerary maxillary left central